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Abstract
Cell tracking is the capability to locate the position and to follow the fate
of cells in living beings over a long period of time. This method might
have a major impact on different sectors of medicine and biology, such as
regenerative medicine or tumor research. Cell tracking permits a better un-
derstanding of cellular processes such as cell migration, cell homing, and cell
function in engraftments at organ or tissue level, or the dynamics of tumor
growth and metastatic spread. Due to the combination of classical imaging
techniques and cellular contrast agents mainly based on nanotechnologies
cell tracking is already feasible. Successful cell tracking has been carried
out using magnetic resonance imaging in combination with superparamag-
netic iron oxide nanoparticles, optical imaging combined with quantum dots
or positron emission computed tomography using unstable β+ nuclides. Al-
though outstanding results have been achieved in specific cases utilizing these
techniques, none of them can be really considered an all-embracing cell track-
ing technique since each of them features specific drawbacks. Despite of the
ubiquitous application of x-ray imaging methods, up to now, x-rays have
been rarely considered as a cell tracking solution because of radiation dose
constrains.
The thesis at hand tries to exploit x-ray imaging methods in the field of
cell tracking. Starting from the x-ray properties an appropriate cellular con-
trast agent, in this case colloidal gold nano particles, and subsequent a load-
ing protocol based on phagocytosis has been chosen and tested. Expected
signal levels, contrasts and signal to noise ratios have been theoretically de-
termined for this specific marker and loading protocol. Then, the detectabil-
ity of marked cells has been verified on in vitro and ex vivo models proofing
the feasibility of cell tracking using gold nanoparticles in combination with
x-ray CT. Successively radiation dose constrains have been examined in de-
tail by means of computer simulations and low dose ex vivo experiments.
The investigation revealed that in vivo cell tracking using x-rays is feasi-
ble and on the basis of these results in vivo experiments had been designed
and prepared. All the necessary authorizations had been obtained by the
National and Local Ethic Committees. First successful in vivo cell tracking
experiments in animal models of human diseases have been performed during
the last months of this thesis work.
The results presented in the following reveal that also x-ray cell tracking
encompasses some limitations such as the previous mentioned techniques,
however it can be consider an alternative and attractive method for cell
tracking.
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Sommario
Il monitoraggio cellulare (anche noto con il termine inglese cell tracking) è
la capacità di tracciare e seguire il destino cellulare in esseri viventi nell’arco
di un lungo periodo di tempo. Tale tecnica presenta un alto potenziale di
impatto in molti settori della medicina e della biologia moderna come ad
esempio nella medicina rigenerativa oppure nelle ricerca oncologica. Il cell
tracking permette una migliore conoscenza dei processi cellulari tra cui: la
migrazione e l’homing cellulare, la funzione cellulare in fase di attecchimento
a livello di organo-tessuto o la dinamica della crescita tumorale e dei focolai
metastatici. Grazie alla combinazione di tecniche di imaging consolidate con
nuovi agenti di contrasto cellulare basati sulle nanotecnologie, le tecniche di
cell tracking possono considerarsi già disponibili. Dalla letteratura sono noti
esempi di cell tracking utilizzando ed esempio: la combinazione della risonan-
za magnetica con le nanoparticelle superparamagnetiche di ossido di ferro,
l’imaging ottico combinato con i quantum dots oppure la tomografia ad emis-
sione di positroni utilizzando nuclidi instabili β+. Nonostante gli eccezionali
risultati ottenuti in taluni casi utilizzando le tecniche menzionate, nessuna di
esse sembra essere una tecnica onnicomprensiva di cell tracking presentando
ognuna qualche sorta di limitazione tecnica. Sebbene l’uso dei raggi x per
imaging sia diffuso in svariate applicazioni sia mediche che industriali, fino
ad ora non sono quasi mai stati presi in considerazione per applicazioni di
cell tracking a causa dei possibili effetti negativi delle radiazioni ionizzanti.
In questo lavoro di tesi si vogliono investigare le proprietà dei metodi
di imaging basati sui raggi x applicandoli al cell tracking. Partendo dalle
proprietà dei raggi x, è stato identificato un appropriato agente di contrasto
cellulare (ovvero le nanoparticelle d’oro) ed è stato scelto e testato un ade-
guato metodo di internalizzazione cellulare delle nanoparticelle basato sulla
fagocitosi. Una trattazione teorica del grado di visibilità cellulare possibi-
le utilizzando tale protocollo è stata eseguita e vagliata da esperimenti sia
in vitro che ex vivo dimostrando di essere in grado di eseguire cell tracking
combinando la tomografia a raggi x con l’uso delle nanoparticelle d’oro. In
seguito sono stati studiati gli effetti di una drastica riduzione della dose di
radiazione sulla qualità dell’immagine prodotta, utilizzando delle simulazioni
al computer e tomografie ex vivo a bassa dose. In questo modo si è dimo-
strato dal punto di vista teorico la fattibilità del cell tracking con i raggi x
in vivo. Sulla base di tali risultati è stato ideato e preparato un esperimento
in vivo di cell tracking ottenendo le autorizzazioni del Ministero delle Salute
e del Servizio Sanitario Regionale, eseguendo infine il primo esperimento in
vivo di cell tracking con raggi x in modelli animali.
I risultati contenuti nel seguente lavoro dimostrano che anche l’uso dei
raggi x nel cell tracking presenta qualche limitazione come tuttavia le tecni-
che menzionate precedentemente. Nonostante ciò esso può essere considerato
un buon metodo alternativo per il cell tracking.
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Chapter 1
Introduction
1.1 Potential of cell tracking
A significant number of sectors in human medicine could benefit from a
deeper knowledge of cell based therapies or in general from a better awareness
of cell processes in living beings [1–4]. To probe biological function or to
explore biological processes such as cell-based therapies or the dynamics of
tumor growth in deep detail it requires new cell tracking techniques.
Cell tracking is the capability to locate and follow the position of cells in
living being over a long time yielding insight into cellular processes such as
migration, homing, function, engraftment at organ, tissue, grow, spread etc.
at cellular level [5].
A successful in vivo cell tracking technique requires an appropriate cellu-
lar contrast agent that provides sufficient signal to be detected by its corre-
sponding imaging technique. The most interesting contrast agents are based
on endogenous markers1, naturally to be found inside the cells or obtained by
protein encoding genes. However, the detectability of endogenous contrast
agents is extremely difficult since the signal levels are very small [2]. In ad-
dition, these small signals are superimposed with signals stemming from non
labeled cells (e.g. autofluorescence in optical imaging [5]), which decreases
dramatically the final effective visibility of labeled cells over the background.
For that reason, in this thesis the attention will focus on exogenous contrast
agents applied to the most widespread imaging technique in the clinical and
preclinical environment, namely x-ray imaging.
According to J.V. Frangioni and R.J. Hajjar [2] the characteristics of an
ideal imaging system for cell tracking based on exogenous contrast agent can
be summarized as in the following (Table 1.1). The contrast agent should
be biocompatible, safe and non toxic. It has to be inert for cells, should not
cause genetic modifications or should not interfere with cell processes. On
the other hand, the imaging technology for such ideal cell tracking system
1 The contrast agents originate inside the cells (intrinsic labels).
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should provide a single cell sensitivity and should permit a correct quan-
tification of the number of cells. Moreover, it should permit the detection
of marked cells at any anatomic location. These last points are critical is-
sues common for all potential cell tracking techniques based on exogenous
contrast agent. They refer to the dilution of the marker-contrast agent dur-
ing cell mitosis, which decreases continuously the visibility of marked cells.
Therefore another requisite is a minimal dilution of the contrast agent dur-
ing cell division and contemporary a minimal transfer between labeled and
non-labeled cells. Finally, the ideal system should be noninvasive to avoid
problems and stress caused by the measurement and it should be applicable
longitudinal over long periods of time without the necessity of injection of
the contrast agent. At present, there are several imaging techniques that are
used for cell tracking, but none fulfills the eight stringent requests presented
at a time in Ref [2].
Table 1.1: The eight characteristics of an ideal imaging technology for stem cell tracking
according to J.V. Frangioni and R.J. Hajjar [2].
Characteristics of an ideal imaging technology
1. Biocompatible, safe, and nontoxic
2. No genetic modification or perturbation to the cell
3. Single-cell detection at any anatomic location
4. Quantification of cell number
5. Minimal or no dilution with cell division
6. Minimal or no transfer of contrast agent to non labeled cells
7. Noninvasive imaging in the living subject over months to years
8. No requirement for injectable contrast agent
1.2 Nanomaterials as cellular contrast agent
With the advent and the widespread use of nanotechnologies during the
last decades a major step forward towards pre-clinical and clinical studies
has been accomplished in cell tracking. In this field nanoparticles (NPs)
or in general nanomaterials, offer incomparable advantages (summarized in
Table 1.2), first of all they have the perfect range of size (1 ÷ 100 nm), small
enough the be internalized by the cells (with a typical size of ∼ 10 µm) in a
large number [6], which allows the partition of the contrast agent during cell
duplication. At the same time the nanomaterials are large enough or can
be modified to be inert. Changing shape, size, and modifying their surfaces,
nanomaterials can be tailored and functionalized with intrinsic properties
(optical, magnetic, biological) that allow numerous bio medical application
of several and complementary imaging techniques on different length scales
[7–11]. Finally, at least some of the nanomaterials are easy to produce at a
18
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low price. For these reasons, the nanotechnology has emerged successfully
in the field of cells tracking and related research.
Table 1.2: The characteristic of nanomaterials for cellular labeling.
Nanomaterials characteristic
1. Small enough to enter the cells
2. Large enough to be internalized with a minimum perturbation of cell
3. Small enough to be internalized in a large number
4. Versatile functionality
5. Wide range of physical properties available
6. Often easy to produce at low costs
1.3 Existing cell tracking methods
As mentioned above, to date there are indeed several imaging techniques
used for cell tracking. Most frequently used are: Optical Imaging (OI),
Magnetic Resonance Imaging (MRI) and Positron Emission Tomography
(PET). These imaging techniques have demonstrated the potential of cell
tracking [1, 12]. In particular, MRI combined with magnetic nanomaterials
is used in preclinical and even clinical environment [13]. In the following the
main characteristics of each of these techniques will be discussed focusing
on their advantages and disadvantages. Following the approach of [5] each
of the techniques will be scored according to important issues such as cost,
radiation, acquisition time, resolution etc. and compared in terms of the
characteristics for in vivo cell tracking with the technique based on x-ray
Computed Tomography (CT) described in this thesis.
1.3.1 Optical Imaging
The basic principle of optical imaging involves a light source (typically
a laser source) that excites a specific contrast agent (often a fluorophore)
and a detector, which captures the photons re-emitted by it. Taking ad-
vantage of higher penetration depth [5] fluorescent probes with emission in
the near-infrared spectra (700 ÷ 1000 nm) have opened the possibility to
perform cell tracking using optical imaging instruments. Another significant
improvement occurred with the advent of Quantum Dots (QDs) [14]. The
latter are inorganic fluorescent semiconductor nanocrystals consisting of a
colloidal semiconductor core (Au, Cd, S, Se, Te, Zn) which is surrounded
by a chemical coating that defines their surface chemistry. Depending on
their composition and their size QDs are characterized by different band gap
energies. This band gap is the minimal energy required to excite an electron
from its ground state into a higher energetic level. After an excitation, when
19
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the electron returns to its (more stable) ground state, a photon is emitted as
a visible fluorescence [15]. The narrow emission and the continuous excita-
tion spectrum allow an easier excitation and at the same time a reduction of
autofluorescence effects increasing the sensitivity of the method up to single
molecule detection. Due to the narrow emission band and using a single
light source QDs permit a multiplexing approach [5, 16]. This means that is
possible to label different kind of cells or different part of the cells using QDs
of different emission “colors” and follow different processes at the same time
(an example of that is shown in Figure 1.1). In comparison to conventional
fluorescence agents QDs have demonstrated high stability in terms of photo-
bleaching and blinking and long biological lifetimes since they remain inside
in vivo tissues for months [5, 14, 16]. Despite successful application in cell
(a) (b)
Figure 1.1: Molecular imaging using QDs. (a) Cellular multicolor imaging of fixed
epithelial cells using five different colors. (b) Representative bioluminescence images of a
nude mouse injected with labeled cells. Figures from Ref [8].
tracking, there are some limitations of QDs based markers, one being their
cytotoxicity which depends on a large number of variables. The safety of
heavy metal QDs and their in vivo use is an ongoing and controversial issue
of debate [17, 18]. As long as the metallic core remains passive (protected
by its shell) QDs seems to be inert. Otherwise it is known that divalent
cations are toxic, even at very low body concentrations (e.g. CdSe). There-
fore the toxicity is related to the stability of the core-shell-coating structure
that needs still to be improved and studied. However this issue might be
solved in the near future [19]. The second limitation is a more critical since
it is related to the inherent physical characteristic of optical imaging. To
mention are here the limited penetration depth in tissue of about 1-2 cm
[15] and the low spatial resolution in the order of 2-3 mm [5]. Eventually, in
most cases the data visualization is bidimensional. Although 3D visualiza-
tion even with adequate spatial resolutions is technically possible [20] and
has been applied in vitro [21] on dissected organs [22] at the moment it is
not commonly available and it is not applicable in vivo.
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1.3.2 Magnetic Resonance Imaging
The most promising imaging technique for cell tracking is probably MRI.
It consists in a powerful magnetic field that aligns a small amount of the nu-
clear magnetization of protons. Radio frequency fields are used to alter
this alignment and produce a detectable signal. Applying specific gradients
and timing of excitations it is possible to reconstruct in three dimensions
the influence of the surrounding atoms on the magnetization realignment of
the perturbated nucleus. The major advantages of MRI are its noninvasive
nature and its large penetration depth. The cellular contrast agent gener-
ally accepted for MRI based cell tracking are superparamagnetic iron oxide
nanoparticles (SPIONs). The wider spread use of SPIONs is due to the fact
that some of them (e.g. Feridex/Endorem and Ferucarbotran) have been
approved for human use by the U.S. Food and Drug Administration as MRI
contrast agents [6]. SPIONs typically consist of an iron oxide core (Fe3O4 or
γ-Fe2O3) that is the active part able to alter the proton relaxation properties
visible using MRI [15].
In terms of number of publications and develop state insomuch that clin-
ical studies are running MRI is the technique more widespread for cell track-
ing [1, 13]. Also for the same reason the limits of MRI in cell tracking are
better known. To mention here is the limited in-plane spatial resolution of
about 25 µm in in vitro samples [23, 24] which becomes in the order of 100-
200 µm in animal studies [23, 25–28]. The axial spatial resolution is worse
and is cited in in vivo examples with approximately 1 mm. This can be
a limitation for the reconstruction of the cells position. In Figure 1.2 two
images from the reference [29] are shown. Depicted are two head slices of
mouse injected with iron labeled cells using a magnetic field of 1.5 and 3 T.
The images have been acquired ex vivo.
254 Magn Reson Mater Phy (2008) 21:251–259
Fig. 1 3D b-SSFP images of a
mouse brain acquired at a 1.5 T
with a BW of ±21 kHz (TR of
7.1 ms), and b, c 3 T with a BW
(and TR) of b ±21 kHz (7.2 ms),
and c ±83 kHz (3.9 ms)
Fig. 2 3D b-SSFP images of a
mouse brain acquired at 3 T with
a BW of ±21 kHz (TR of
7.2 ms) without (a) and with (b)
MI-SSFP
Fig. 3 The upper and lower
panels each show two
representative 3D b-SSFP
images of iron-labeled
MDA-MB-231BR cells in two
mouse brain slices, imaged
3 days after an intracardiac
injection of cells, acquired with
the same spatial resolution
(100× 100× 200µm3),
bandwidth (±21 kHz) and scan
time (100 min) at (a, c) 1.5 T
(7.0/3.4 ms) and (b, d) 3 T
(7.1/3.5 ms). Arrows indicate
signal voids detected at 3 T only
of the image data sets and the appropriate paired Student’s t
tests, with a significance level of 5%, were performed.
Results
The mean cellular iron content was found to be ∼50 pg/cell.
Figure 1 shows ex vivo b-SSFP images, of a mouse brain,
acquired at 1.5 and 3.0 T. Images in 1a and b are b-SSFP
images obtained at 1.5 T (a) and 3 T (b) with the same para-
meters. Banding artifact is substantial in the 3 T image; BW
was±21 kHz and TR was 7.2 ms. When the TR is minimized,
accomplished by increasing the BW, the banding artifact is
reduced. With a TR of 3.9 ms (BW = ±83 kHz) the banding
artifact is almost completely eliminated in the 3 T image (1c).
The main drawback to this approach was the decreased SNR
associated with larger BW.
Figure 2 shows b-SSFP images of the same mouse brain
specimen acquired at 3 T without (a) and with (b) MI-SSFP.
These images were acquired with a BW of ±21 kHz and
TR = 7.2 ms. Mi-SSFP effectively reduced banding arti-
fact without any adverse effects on SNR. For this reason,
MI-SSFP was implemented as the method of choice to
eliminate banding for all further imaging.
Images acquired at 1.5 and 3.0 T with the same resolu-
tion and scan time are shown in Fig. 3. These images were
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(b)
Figure 1.2: Mouse rat brain (ex vivo) injected with iron labeled cells imaged in 100 min
at same spatial resolution (100×100×200 µm3) (a) at 1.5 T (b) and 3 T. Figures from Ref
[29].
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Despite of the low spatial resolution (∼ 100 µm), which is approximately
10 times greater than a cell, the labeled cells are clearly visible as black dots,
but the reconstruction of the cell position suffers from the low resolution.
Often discussed in this context is the sensitivity of MRI, that is the minimum
number of SPIONs labeled cells, which is detectable. Although a single cell
sensitivity has been demonstrated using a high field magnet (11.7 T) and
a labeling protocol based on a large, single iron particle (0.76-1.63 µm in
size) [30], the feasible study is hardly translatable towards pre-clinical trials.
Moreover the use of a single particle is limited to studies of cells prior mitosis.
More doable in vivo experiments report a detection limit of 103-105 cells
[25]. A last limitation of MRI is its substantial initial and running costs
especially for high field machines which outperforms those of x-ray CT and
optical imaging.
1.3.3 Positron Emission Computed Tomography
Positron Emission Computed Tomography (PET) uses an injectable con-
trast agent, which contains unstable β+ nucleus. The main physical process
behind it is the emission of a positron (the antiparticle of the electron), which
looses its energy during a short travel inside matter (typically around 1 mm)
and then annihilates with an electron producing two anti-parallel 511 keV
photons. These two photons are acquired by two detectors that evaluate the
“coincidence event” (sign of photons originated by the same annihilation)
along a straight line of coincidence. The main advantage of PET is the ex-
treme sensitivity (down to nmol) that allows to image sample even at very
low concentration [31]. In Figure 1.3 it is depicted an example of an in vivo
µ-PET of a mouse injected with 64Cu-PTSM-labeled C6 cells [32].
cells was inhibited potently (!100-fold lower) in high-glucose
medium (data not shown). Therefore, glucose-free medium was
used in FDG experiments. At the FDG concentrations tested
(1.5–12.4 !Ci!ml), labeling efficiency was not dose-dependent,
suggesting saturation of transporters (data not shown).
Both 64Cu–PTSM and FDG Efflux from C6 Cells.To evaluate the efflux
rate of 64Cu–PTSM and FDG, leakage of radioactivity into
tracer-free medium from labeled C6 cells was measured. As
shown by the diminishing cell-associated activity in Fig. 3, both
tracers rapidly eff lux from C6 cells. Serum did not influence the
rate of 64Cu–PTSM release, but glucose accelerated FDG efflux.
64Cu–PTSM retention was examined numerous times (n " 20)
because of considerable variance after 5 h of eff lux (#20%
retention). Visual inspection of cells under a light microscope
revealed that there was a substantial and progressive loss of cell
adherence to plate over time. The cell detachment from plate
may be a result of repeated washes, inadvertent aspiration,
increasing confluence, and!or cell death and would overesti-
mate 64Cu–PTSM efflux and account for the experimental
variance observed at later time points in Fig. 3.
64Cu–PTSM Labeling Procedure Imposed Minimal Cytotoxicity. The
trypan blue dye exclusion and MTT assays evaluate living cells
based on intact plasma membrane and metabolic activity, re-
spectively. As measured by trypan blue, C6 cells labeled with
64Cu–PTSM for 35 and 270 min, showed 85 and 80% viability,
respectively, with no significant difference in viability of cells
similarly labeled with FDG (data not shown). Unexposed con-
trols had an average viability of 92–94%. In contrast, only 2–5%
of cells exposed to UV light for 35 and 270 min remained viable.
The percent viability of C6 cells at 20 h postlabeling was
80–85%. Living cells convert the tetrazolium component of the
MTT dye (yellow) into a formazan product (blue). Because
intensity of the resulting color change is proportional to the
number of living cells, tetrazolium salt reduction can be used
both as a measure of cell viability and proliferation. There was
no significant difference in MTT reduction by 64Cu–PTSM-
labeled C6 cells and unlabeled controls, neither immediately nor
up to 24 h after the 5-h labeling period, indicating 64Cu–PTSM
labeling does not alter cellular proliferation (data not shown).
64Cu–PTSM-Labeled Cells Can Be Imaged Noninvasively in a Living
Mouse by Using a MicroPET Scanner. To demonstrate that the
microPET scanner can detect the presence of cells in association
with 64Cu, mice were injected via tail vein with 94,500 64Cu–
PTSM-labeled C6 cells (Fig. 4A). Because the location of activity
in the microPET image (Fig. 4A) correlates with the autoradio-
gram (Fig. 4C), the anatomic origin of activity can be determined
by matching the autoradiogram with its corresponding photo
(Fig. 4B). Thus, Fig. 4 demonstrates that 0.45 h after injection of
64Cu–PTSM-labeled C6 cells, most of the activity is in the lungs
(97.2# 3.37%ID!g), and some is present also in the liver (6.96#
0.81%ID!g) and gut (1.31# 0.04%ID!g). MicroPET images of
mice at 0.23 h after injection of labeled C6 cells show distribution
of activity in the lungs (99.2# 6.31%ID!g) and the liver (4.82#
0.90%ID!g). By 18.8 h, activity redistributes from the lungs
(4.78 # 0.49%ID!g) to the liver (13.6 # 1.69%ID!g) (data not
shown). Gut activity increases slightly from 0.56 # 0.02%ID!g
(0.23 h) to 1.64 # 0.65%ID!g (18.8 h). DWBA verified that the
liver was the primary anatomic origin of the radioactivity at
18.8 h.
To compare the biodistribution of 64Cu–PTSM-labeled C6
cells to free 64Cu–PTSM, mice were imaged also after injection
of 64Cu–PTSM. Extensive studies on the tissue-specific mecha-
nisms of Cu–PTSM extraction and retention have revealed that
Cu–PTSM is predominantly metabolized and cleared by hepa-
tocytes, which is reviewed in detail by Blower et al. (9). Accord-
ingly, microPET images of mice i.v.-injected with free 64Cu–
PTSM showed primarily hepatic clearance of radiocopper at
0.10 h (10.7# 0.50%ID!g) and 20.3 h (10.3# 1.94%ID!g) (Fig.
5 A and B). In contrast to 64Cu–PTSM-labeled C6 cells, injection
of free 64Cu–PTSM results in minimal activity in the lungs both
at 0.10 h (3.30 # 0.41%ID!g) and 20.3 h (2.34 # 0.51%ID!g).
Organ biodistribution measurements in additional mice injected
with either free or C6 cell-labeled 64Cu–PTSM corroborates the
microPET results (data not shown).
As shown in Fig. 6, 64Cu–PTSM also can be used to track the
systemic migration of lymphocytes. Similar to C6 cells (Fig. 4),
injection of 64Cu–PTSM-labeled lymphocytes initially (0.12 and
3.33 h) leads to lung localization of activity (51.8 # 1.15 and
13.1 # 0.23%ID!g). By 18.9 h, very little activity remains in the
lungs (2.41# 0.19%ID!g; Fig. 6). As the lung activity decreases,
liver activity increases (9.94 # 0.25, 18.4 # 0.64, and 16.7 #
0.95%ID!g at 0.12, 3.33, and 18.9 h, respectively). In contrast to
C6 cells, after injection of lymphocytes activity clearly localizes
to the spleen (11.8 # 0.91, 32.9 # 0.91, and 9.93 # 0.42%ID!g
Fig. 3. 64Cu–PTSMandFDGretentionby labeledC6 cells as a functionof time.
This graph reflects the intracellular stability of 64Cu–PTSM and FDG as a
function of time. FDG efflux was measured at 4 rather than 5 h on this graph.
Rapid tracer efflux indicates slow trapping. Each bar represents the mean
percentage label retained # SE of triplicate wells.
Fig. 4. In vivo microPET imaging of 64Cu–PTSM-labeled C6 cells post i.v.
injection into a mouse. This mouse was microPET-scanned at 0.45 h postinjec-
tion of C6 cells (4.27 !Ci). Immediately after the scan, themousewas killed (at
1.45 h) for DWBA. (A) The average of nine coronal planes from the WB
microPET image. (B) Photo of the DWBA section shown in C. Concordance
between location of activity in the microPET image and DWBA section dem-
onstrates that cells are trapped initially in the lungs. The%ID!g scale is shown
for quantification of the microPET signal.
Adonai et al. PNAS " March 5, 2002 " vol. 99 " no. 5 " 3033
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Figure 1.3: An in vivo µ-PET of a mouse injected w th 64Cu-PTSM-labeled C6 cells.
Figures from Ref [32].
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The main disadvantages of PET are related to the half-life of the radionu-
clides. The isotopes2 used have typically a short half life (11C ∼ 20 min, 13N
∼ 10 min, 15O ∼ 2 min, 18F ∼ 110 min), therefore they must be produced
using a cyclotron in close proximity to the PET facility. This short life time
limits the stability of the contrast agent that is around minutes-days [5] and
consequently it limits the cell tracking capability for long term studies. The
advantages are a high penetration depth of the detectable nuclides and (as
already mentioned) the high sensitivity. On the other hand the reconstruc-
tion resolution is poor, around 1-2 mm and the radiation dose delivered can
limited the number of exam to the same patient-animal and cause genetic
modifications of the cells.
1.3.4 X-ray Computed Tomography
Since a complete description of the x-ray CT will be presented in Chapter
2 in the following a brief summary of CT properties will be discuss to justify
the use of CT for cell tracking comparing it with the previous mentioned
techniques. X-ray imaging consists in an x-ray source that irradiates the
examined sample and a 2D detector that acquires and stores an image related
to the transmitted photons. Collecting hundreds of 2D projection images
while rotating the sample it is possible to reconstruct a 3D map of the
absorption properties of the object.
In clinical practice CT imaging has a low-medium cost profile for the in-
strumentation and the running costs since the throughput is high. Typically
an x-ray CT acquisition takes between minutes to some tenth of minutes,
which depends on the x-ray source, and the required spatial resolution. The
penetration depth of the x-rays is a function of their energy but can be
consider without limits at least in small animal or human imaging. In prin-
ciple the spatial resolution can be extremely high for example using µ-focus
sources (even around few µm) but it is restricted to ex vivo imaging or by x-
ray dose constraints that put limits on in vivo imaging. The latter represents
the main disadvantages of x-ray in in vivo cell tracking studies. From the
cell markers point of view, CT needs high x-ray absorbing materials that can
be chosen between the well-known x-ray contrast agents. A study of human
stem cells x-ray cell tracking in mice has carried out using FeO NPs [33].
The work proofs the feasibility to visualize marked cells with high resolution
on small muscle biopsies (∼ 23 mm3) using x-rays and the attenuation prop-
erties of the label. Therefore, in principle, it is possible to use safe, stable
and non toxic cellular contrast agent in combination with x-ray CT.
2 Atoms of the same element having different number of neutrons.
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1.4 Cell tracking techniques comparison
A brief overview of cell tracking techniques have been presented in the
previous Section. Advantages and disadvantages of each single technique
have been combined and they are presented in Table 1.3 to permit a faster
and easier overview. Each technique presents advantages and weak points
and impartial consideration are impossible. Without the pretension to dis-
close this impasse, but only with the goal to summarized the situation, a
three scale score (3 equals “best results” and 0 equals “worse results”) has
been assigned to each technique property compared to the others. The total
score obtained is not a general assessment of the techniques because each
cell tracking experiment must be calibrated around the technique and the
contrast agent chosen depending strongly by the phenomena under study.
Sometimes a specific cell tracking technique is the best or the only choice in
particular cases. Nevertheless it shows few important facts. First, no one
technique has received more than the 70 % of the maximum reachable score.
It confirms that there is not a perfect technique that can resolve the entire
cell tracking requests. Second, the x-ray CT has the potential to compete
with strong cell tracking techniques such as MRI. This motivates our scien-
tific curiosity to investigate the potential and the limits of x-ray CT to offer
a novel x-ray based method for cell tracking.
1.5 Future prospective
It has been shown in the previous Section that each imaging technique
mentioned is somewhat limited to certain characteristics requested in an ideal
cell tracking imaging technology. The introduction of multimodality hybrid
imaging technologies and markers could overcome part of the previous men-
tioned weaknesses. The rationale of multimodality imaging is to combine
a low-sensitivity modality with high spatial resolution and tissue contrast
(CT or MRI) with another low-resolution but high sensitivity modality. [34]
Commercially available systems include PET-CT, PET-MRI and even PET-
CT-MRI. [35] On the other hand hybrid contrast agents can show proper-
ties exploitable with different imaging techniques such as a Gd-Au based
contrast agent for CT-MRI [36], gadoflurine M-Cy3.5 for MRI-OI [37] or
polyelectrolyte multilayer coated gold NPs with fluorescent stains for CT-OI
[38]. Even three techniques combination has been used for tumor studies
combining PET, CT and OI [39]. Except the cost requirements, the multi-
modal approach seems to be the right way to go for an optimal and complete
cell tracking technique really close to the ideal technique imagined by J.V.
Frangioni and R.J Hajjar in [2].
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Chapter 2
X-ray Cell Tracking
2.1 Introduction of x-ray
X-rays are electromagnetic waves encompassing substantial smaller wave-
lengths than visible light. X-rays have been used in biomedical applications
almost immediately after the discovery [40] that the intensity of an x-ray
beam, as measured by the exposure on a film, was related to the relative
transmission properties of an object and thus to its linear absorption coef-
ficient. Already in February 1896 the first clinical x-ray images were taken
[41] and still nowadays x-rays are an indispensable tool in diagnostic imag-
ing. As a century ago x-rays are usually produced by x-ray tubes. Depicted
in Figure 2.1 is a schematic view of a stationary anode x-ray tube. A glass
vial accommodates in vacuum a tungsten filament (cathode) and an anode.
The choice of the anode material depends on the specific application. A
electric current flowing in the filament circuit causes a thermionic emission
of electrons (cathode), which are accelerated by the external electrical field
V towards the anode. In the anode material the electrons are decelerated
and eventually thermalized. In medical diagnosis imaging, the maximum ac-
celeration voltage is in the order of 150 kVp (peak kV) which is equivalent to
the maximum kinetic energy of the electrons. Inside the anode the electrons
losing energy by ionization and (in a smaller part) by bremsstrahlung which
is emitted in form of x-rays in a continuum spectra.
With the advent of synchrotron radiation (SR) in the 60s of last cen-
tury a major improvement in the production of x-rays occurred. The main
properties of SR are a high angular collimation of the beam and a high inten-
sity. Moreover, using crystals it is possible to obtain monochromatic x-ray
beams throughout a wide spectrum of energies. In a synchrotron electrons
are organized in bunches, which are accelerated close to the speed of light
(c) in a nearly circular ring. The associated centripetal acceleration causes
the electrons bunches to emit energy in form SR. The power emitted by
27
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x-rays 
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Figure 2.1: Schematic view of a stationary anode x-ray tube.
an ultrarelativistic1 charged particle per solid angle unit accelerated on its
orthogonal direction is strongly directed forward direction. In a first approx-
imation the SR is planar and it appears in the laboratory frame like a fan
opened in the orbital plane (Lorentz boost as is shown in Figure 2.2). This
is a consequence of the angular distribution of the emitted radiation and
which is due to the electrons bunch that is squeezed in the orbital plane (the
ratio between the vertical and the in-plane dimensions is ∼ 1:10). As con-
sequence the vertical collimation is ∼ 1/γ, the horizontal one depends from
the electrons bunch width [42]. At an electron energy of GeV the angular
distribution is around 0.25 µrad, that permits very collimated beams. SR is
characterized by a continuous spectrum ranging from few eV to some tenths
keV (thus the wavelength ranges from infrared to x-rays) and its brightness
(as defined photons/s/mm2/0.1%bw) is 6-8 orders of magnitudes higher than
conventional x-rays sources [43].
2.2 X-ray imaging
A generic radiological system is summarized in the block diagram of
Figure 2.3. It consists of an x-ray source that irradiate the sample. Behind
the sample transmitted photons are collected by a suitable x-ray detector
attached to a image processing unit that permits to visualize the x-ray image
of the sample in terms of gray values or similar color scales. [44]
1 that means γ = (1− β2)−1/2 1, β = v/c
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Figure 2.2: Laminar geometry (on the orbit plane) of a bending magnet SR beam.
2.2.1 The contrast formation
Taking into account the absorption properties of human tissue it has been
found that the best photon energy for diagnostic x-ray imaging lies between
15 and 150 keV. In this energy range photons interact with matter through
atomic electrons. The main interactions are: elastic scattering (Thomson
and Rayleigh effect), inelastic scattering (Compton effect) and absorption
(photoelectric effect). Briefly, during an elastic scattering process incident
photons preserve their energy but they are deviated from their original di-
rection; also during an inelastic scattering process photons are deviated from
their original path however, this time combined with a loss of energy. Dur-
ing a photoelectrical absorption process photons release their entire energy
in matter. It collides with an atom and ejects one of the bound electrons
from the K, L, M, or N shells. The ejected electron called photoelectron
loses its energy into the matter leaving the atom in an exited state that sub-
sequently emits characteristic radiation and Auger electrons returning in its
ground state. [45] The latter process (photoeffect) can be followed by the
emission of an Auger electron emission or the emission of a monochromatic
(characteristic emission peaks). Each of these processes has a proper prob-
ability to happen, which is a function of the energy of the photons and of
the examined material. At lower photon energies the photoelectric effect is
more probable than the Compton effect that dominates at higher energies.
x-ray 
source 
sample 
(patient) 
detector image 
processing 
visualiza
tion 
Figure 2.3: Functional diagram of a generic radiologic instrumentation.
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This happens because the photoelectric cross-section, that is at our working
energies [46, 47]:
σph ∝
Z4
E3.5
[2.1]
where Z is the atomic number and E is the photon energy, decreases with the
photon energy; instead the Compton effect depends weakly from the energy.
In the following the process of image formation in the x − y detector plane
will be described as function of the object linear attenuation properties in
the x − y plane in a parallel beam geometry. Let φ0 be the initial photon
flux (number of photons per unit time and unit area) passing through a slap
of the thickness z of a certain material. We consider a monochromatic beam
and we further assume that φ(z) is the transmitted photon flux measured
at the position z. Consequently the number of photons interacting with the
matter per unit time and unit area by and infinitesimal thickness dz is:
dφ(z) = −µφ(z)dz [2.2]
where µ is a proportional factor called linear attenuation coefficient. It repre-
sents the probability of interaction per unit length. Considering µ constant,
the integral of Equation 2.2 is:
φ(z) = φ0e−µz [2.3]
The attenuation coefficient depends on the cross-section σ of the interaction
and on the electronic density of the material ρe (number of electrons per unit
volume):
µ = σρe [2.4]
The cross-section as well as µ depends on the photon energy (E). In case of
multiple atomic interactions as it is the case in x-ray imaging, the total cross-
section is the sum of all cross-sections σi of the process involved. Therefore
the total attenuation coefficient is the sum of all the attenuation coefficients
µi:
σtot =
∑
i
σi ⇒ µtot =
∑
i
µi [2.5]
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Consequently, in Equation 2.2, the coefficient µ must be substituted with
µtot that includes all the photons interaction. In the following it will be
implied in µ.
The image is created by the different attenuation within the sample and
depends in general by (x, y, z) and the photons energy E. The photon flux
that reaches the detector plane φin in the point (x, y) is the sum of the
primary radiation, that has crossed the sample without interactions, and
the secondary radiation due to scattering processes. Neglecting scattering
processes in the point (x, y) one can write:
φin(x, y) = φ0(x, y)e
−
∫
µ(x, y, z)dz
[2.6]
where φ0 is the incident photon flux and the integral is calculated along the
path z (the integral is also called “ray sum”). The number of photons that
will reach a finite detector pixel (xi, yj) is:
Nin(xi, yj) =
∫
∆t
∫
∆xi
∫
∆yj
φin(x, y)dtdxdy [2.7]
where ∆xi and ∆yj are the pixel (xi, yj) dimensions and ∆t is the exposure
time. The contrast that permits to visualize and distinguish differences on
µ(x, y, z) stems from the difference on the number of photons on the detector
plane. The mean signal S of a generic detail A can be written as:
S =
1
n
∑
(i,j)∈A
Nin(xi, yj) [2.8]
where the sum adds up over the n pixels that correspond to a detail. Let
consider the example in Figure 2.4 where an absorbing homogenous sphere
is illuminated by an incident laminar x-ray beam and the attenuated profile
is acquired by a one-dimensional Charge Coupled Device (CCD) detector.
The number of photons Nin(xi) behind the sphere depends on the sphere
thickness along z and it changes with the position x. One can calculate the
sphere mean signal S2 using the Equation 2.8 over the pixels in the sphere
shadow (A2) and also in its background S1 over the pixels in A1. The sphere
contrast is given by:
C =
S1 − S2
S1
[2.9]
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Figure 2.4: Scheme of a conventional x-ray image. The incident beam is attenuated
by the sample. The informations related to the sample attenuation will be stored by the
CCD pixels indicated with A2. The background signal will be in the A1 CCD pixels.
Another important imaging quantity that is important to introduce is
the Signal to Noise Ratio (SNR) that measures the visibility of a detail. It
can be interpreted as the contrast (the numerator S1−S2 is proportional to
C) weighted by its background noise σS1 :
SNR =
S1 − S2
σS1
[2.10]
The SNR describes the visibility of detail taking into account the fact that the
image noise is a crucial parameter on the human visual capacity to separate
different details.
2.3 Introduction to phase contrast
In the previous sections it has been explained that the usual x-ray images
are based mainly on total attenuation processes as photoelectric effect and
scattering effects (coherent and incoherent). In high Z materials the photo-
electric effect dominates from few keV up to ∼ 200 keV (see Equation 2.1).
Biological materials characterized by low Z show significant scattering ef-
fects. In particular the coherent scattering can be exploited in the relatively
recently introduced phase contrast techniques that use the waves phase shift
as contrast source. [48–52] A wave optical approach introducing the index
of refraction n is fundamental to describe x-ray phase processes:
n = 1− δ + iβ [2.11]
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In Equation 2.11 the imaginary part β describes absorption processes and
the real part δ the phase shift. The linear attenuation coefficient µ already
described in Section 2.2 is related to the coefficient β by the following rela-
tionship [53]:
µ =
4piβ
λ
[2.12]
Since the x-ray detectors are sensitive to intensity patterns it is necessary to
transform the phase function Φ(x, y) in an intensity modulation in order to
acquire a phase contrast image. Different experimental approaches can be
grouped in three categories: x-ray interferometry, diffraction imaging and in-
line holography that correspond to measure Φ(x, y), ∇Φ(x, y) and ∇2Φ(x, y)
[54]. At the common energies used in x-ray imaging, the δ coefficient is
usually larger than the β, up to 2-3 order of magnitudes [53]. Therefore, the
exploitation of δ-based contrast imaging can improve the detail visibility in
the object.
2.3.1 Edge enhanced regime
In-line holography is the simplest phase contrast technique because it
does not imply the use of special optics or equipment as x-ray interferometry
and diffraction imaging. With the only requirement of a source with sufficient
lateral (or spatial) coherence it is possible to detect the effects of phase
perturbation, resulting in an enhancement of image contrast [48]. For SR a
typical vertical size s of the source is about 100 µm and for long beamlines
the source-sample distance r is some tenth of meters. Consequently the
coherence length Ls = λr/(2s) for hard x-rays around 20 keV can be up to
some tenth of µm. As discussed previously the x-ray wave field when it passes
through an object is phase shifted. The waves refracted by a detail interfere
with the not refracted waves traversing the background. This interference
effect takes place along the border of the detail inside a narrow angular
region (about 1-10 µrad) and it results in strong interference patterns inside
this region that could be detected as it is depicted in Figure 2.5. In the
example the sphere sample is characterize by β = 0 and δ 6= 0 (“weak object”).
Since the interference angle is very small, in order to detect the interference
patterns one has to optimize the sample-to-detector distance d considering
also the spatial resolution of the detector. Obviously in order to appreciate
these interference fringes detectors with high spatial resolution are necessary.
The interference patterns are more pronounced at the edges of the details and
they are revealed as strong intensity variation in the image. In particular this
edge-enhancement effect increases the visibility of the very thin and small
details, usually almost invisible on the absorption image.
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Figure 2.5: Scheme of an imaging setup in “edge enhanced regime”. In case of high coher-
ence length (Ls) the weak absorbing sample generates an interference pattern detectable
at distance d that is more pronounced at the detail edges.
2.3.2 X-ray interferometry
With respect to in-line holography methods x-ray interferometry in gen-
eral requires a more complex setup. However the advantage is to obtain
the phase function Φ(x, y). An example of the x-ray interferometry setup
is the “grating interferometer” (GI) introduce by Weitkamp et. al. in 2005
[55]. The GI technique consists in a phase grating G1 providing a substantial
phase shift and a negligible absorption and an absorption grating G2 as de-
picted in Figure 2.6. G1 acts as a beamsplitter that divide the beam into two
diffracted beams that interfere creating a fringe pattern if illuminated by a
planar or spherical wave. The periodicity g of the fringe pattern for a phase
shift of pi illuminating with a plane wave is equal of G1 half period. Neither
g nor the fringe lateral position depends on the wavelength used. [55] As
depicted in Figure 2.6, any perturbation of the incident wave perturbs the
fringes pattern. This technique consists of measuring the perturbed fringe
position to retrieve the phase Φ(x, y). Since the pitch of the interference
fringes does not exceed few microns (much smaller than a common area de-
tector) the method uses the absorbing grating G2 in front of the detector
transforming the local fringe position into an intensity profile. [55] The G2
grating is scanned along the xg direction over one period and an image is
acquired per each grating step sampling the fringe intensity. In each detector
pixel the phases of the intensity oscillation is [56]:
ϕ(x) =
λd
g2
∂Φ(x)
∂xg
[2.13]
where λ is the x-ray wavelength and g2 the absorption grating period. The
phase information Φ(x) is retrieved by a one-dimensional integration of Equa-
tion 2.13.
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Figure 2.6: Scheme of the grating interferometer. The sample presence interferes with the
fringes generated by the phase grating G1. Using the absorbing grating G2 the perturbed
fringe maximums are measured by the CCD detector through a stepping sampling of G2
along xg.
2.4 X-ray Computed tomography
In Section 2.2 the general planar x-ray image has been introduced to
visualize 2D images of the attenuation coefficient µ(x, y, z) integrated over
the x-ray direction propagation. Thus in planar images all the 3D informa-
tion are lost due to the ray sum. CT has the property of rescuing the 3D
information of µ(x, y, z) starting from several (typically hundreds) of pla-
nar images obtained by rotating the sample. 3D information are essential
to reconstruct the cells positions in a cell tracking technique. Considering
the incident photon flux φ0 constant on all pixels and a constant acquisition
time, the number of photons N0 per pixel is:
N0 =
∫
∆t
∫
∆x
∫
∆y
φ0(x, y)dtdxdy = φ0∆t∆x∆y [2.14]
We introduce the rotated coordinate system (x, yr, zr) depicted in Figure
2.7. It describes the beam−detector reference frame, which turns around
the x (vertical) axis, rotating with respect to the object reference frame
(x, y, z). Thus, for any projection identified by the angle θ, zr is the optical
axis, (x, yr) denotes a position in the detector plane and Lθ(x, yr) defines
the path of the photons reaching the detector in (x, yr). [57, 58]
Therefore, the number of photons Nin detected on the rotated detector
in the pixel (xi, yrj ) becomes:
Nin(xi, yrj ) = N0e
−
∫
Lθ(x,y
r
j )
µ(xi, yrj , z
r)dzr
[2.15]
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Figure 2.7: Definition of the coordinate systems. The object reference frame (x, y, z)
and the beam-detector reference frame (x, yr, zr) are rotated by the view angle θ around
the x axis with respect to each other.
where µ(xi, yj , z) is the discretization of the attenuation coefficient. Mathe-
matically it is possible to separate the measured quantities from the unknown
ones, obtaining:
− ln Nin(xi, y
r
j )
N0
=
∫
Lθ(x,y
r
j )
µ(xi, yrj , z
r)dzr [2.16]
The recovery of the unknown information µ(x, y, z) starting from indirect
measurements that in our case are the projections Nin(x, yr) is part of what
is known in applied mathematic as an inverse problem. A description of
the CT reconstruction is beyond the scope of this work, therefore for further
investigations a complete reference is available in “Principles of Computerized
Tomographic Imaging” written by A. C. Kak and M. Slaney [59].
In practice considering a simplified parallel beam geometry (which is close
to the SR CT case), hundreds of projections of the object are acquired rotat-
ing it as depicted in Figure 2.7. Each line at x = xi of the acquired images
Nin(yr)xi is a different angular view of the sample slice i. It is convenient to
order all the slice views in a single image Nin(yr, θ)xi called sinogram. Each
sinogram contains all the slice informations needed for its reconstruction that
is commonly performed using the “filtered back projection” algorithm.
Obtaining in CT images of µ(x, y, z), becomes natural reformulate the
previous introduced quantities as:
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Cµ =
µ1 − µ2
µ1
[2.17]
SNRµ =
µ1 − µ2
σµ1
[2.18]
Being most of the images coming from CT, in the following the subscripted
µ will be implied. With the aim of investigating x-ray imaging for bio-
logical application in vivo, the x-ray dose delivered to the animal becomes
crucial. The dose constrains are particular important in x-ray CT where
several projections are acquired. A general approximated formula for the in
air integrated dose is [60]:
dose ∝ 2[e
µ1D + 1]
DQE
SNR2
µ21w
4C2
E
(
µair
ρair
)[
1
2
+
1
2pi
∫ +pi/2
−pi/2
e−µ1D cos θdθ
]
[2.19]
where D is the sample dimension, w is the detail dimension, µ0 and ρ0 are
the air linear attenuation coefficient and the air density respectively, and θ
is the CT scanning angle. The formula is only an approximation obtained
for a simplified geometry but it can be useful to understand the behavior
of the radiation dose. Finally, in experiments where the dose reducing is
important, the quantity called Figure of Merit (FoM), defined as [61]:
FoM =
SNR√
dose
[2.20]
permits to evaluate the SNR normalized to the radiation dose.
2.5 Properties of x-rays in cell tracking
In Chapter 1 the characteristics of an ideal imaging technique for cell
tracking has been discussed. As summarized in (Table 1.1) the ideal imaging
technique requires biocompatible, safe, nontoxic and non-injectable contrast
agents which should not interfere with the cell functionality. It would require
single cell detection sensitivity at any anatomic location and should allow the
quantification of cell numbers. An ideal marker would not or only minimally
dilute with cell division and would have a minimal transfer to non-labeled
cells. The ideal imaging system should allow non-invasive imaging in living
subjects over months or years. [2] In this section all the requirements will
be studied with special regard to cell tracking using x-rays.
First of all x-ray imaging has several inherent advantages that can be
summarized in:
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High resolution the higher energy of the photons permits to decrease
the intrinsic limit in spatial resolution with respect to other imaging
technique (OI, MRI, PET). Spatial Resolution of about 10 µm are
achievable using conventional µ-focus x-ray tubes;
High penetration As discussed in Chapter 1 the properties of the x-
rays permit a high penetration depth that increase significantly with
higher energies. It is possible to scan a human body;
Fast acquisition commonly an x-ray CT scan is fast, around minutes
for a mid resolution total body acquisition;
Medium cost the cost of an x-ray CT device is lower than MRI or PET
instrumentation;
Readily available the x-ray systems are widely widespread and avail-
able.
Thus using x-ray CT techniques it should be in principle possible to retrieve
a single cell at any anatomic position and to quantify cell numbers (point 3
and 4 in Table 1.1). However, the disadvantage of x- ray CT is accounted for
the delivered radiation dose (point 8 in Table 1.1). A noninvasive imaging
tool based on x-rays should be operated only with such radiation dose that
would not harm the being under exam. In the following chapters a detailed
study of the radiation dose for in vivo cell tracking using x-rays will be
presented.
2.5.1 Gold nanoparticles as x-ray contrast agent
From the previous discussion it is obvious that cell tracking requires
a suitable contrast agent for cellular recognition tailored according to the
properties of the imaging technique. Five over the eight points of the ideal
cell tracking technique concern the contrast agent and its biological effect on
cells. As seen on Chapter 1 the most suitable contrast agents at cellular level
are based on nanotechnologies because they are small enough to enter the
cells and big enough to not compromise its functionality (at least in certain
cases). In general, x-ray contrast agents are characterized by an high atomic
number because of its higher linear attenuation coefficients (µ). Keeping
fixed the contrast, the higher µ the smaller the amount of cellular marker
needed. Conventional x-ray contrast agents are: iodine (Z = 53), barium
(Z = 56) and gadolinium (Z = 64). Only relatively recently also the use of
gold nanoparticles solution (Z = 79) has been considered as injectable x-ray
contrast agent [38, 62] that offer a better absorption with respect to others
at same concentration. Supposing to been able to create NPs with the same
diameter and load some cells with the same amount of NPs, Figure 2.8 shows
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the linear attenuation coefficient of the mentioned contrast agents as func-
tion of the photons energy. In the supposed case, the gold attenuation is 12
÷ 15 times bigger then the other contrast agents between 15 keV and 33 keV
photon energy. Therefore gold NPs are an interesting candidate as contrast
agent for x-ray cell tracking, because it yields higher contrast or requires a
lower marker concentration providing the same contrast. This is an impor-
tant fact because cells loaded with an exogenous marker can change their
normal cell functionality also because of the presence of a large amount of
unknown material [63, 64]. Another point is the capability to effectively load
the cells with the selective contrast agent and the cell reaction. The marker
presence must be inert in terms of cell viability, proliferation, etc. being in
other works biocompatible, safe and nontoxic. Moreover, the initial quantity
of incorporated marker should be sufficiently high to be detectable also after
several mitosis. Besides the marked cells should hold the contrast agent over
long time without transfer to non-labeled cells. Studies using SPION as cell
label in combination with x-ray CT have been reported [33, 65]. Being a cel-
lular MRI contrast agent the use of SPION allows complementary imaging
studies using MRI. Nevertheless its lower x-ray attenuation coefficient and
subsequently lower contrast compared to gold (plotted in Figure 2.8) implies
to increase of the amount of cell markers per cells or to increase the applied
x-ray dose.
2
3
4
5
6
7
100
2
3
4
5
6
7
1000
2
3
At
te
nu
at
io
n 
[c
m
-1
]
40353025201510  Energy [keV]
 Gold
 Iodine
 Barium
 SPIO
Figure 2.8: Graph of the linear attenuation coefficient for gold, iodine, barium and
SPION contrast agents in function of photon energy.
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Chapter 3
X-ray instrumentations
Cell tracking with x-rays requires sophisticated instrumentation to render
the weak signal stemming from the marked cells with sufficient SNR. For that
reason a deep understanding of the employed instrumentation is required.
This includes knowledge of stability, energy range, source size regarding the
x-ray source resolution, and knowledge of dynamic range, efficiency and noise
of the utilized detectors. In the following the instrumentation used in the
experiments presented in this thesis, and which have been available at the
x-ray facility ELETTRA in Trieste are described in detail.
3.1 X-ray sources used
3.1.1 The SYRMEP beamline at ELETTRA
ELETTRA is the Italian synchrotron radiation facility located in Baso-
vizza (Trieste),1 which is routinely operated at two electron energies, namely
2.0 GeV and 2.4 GeV, respectively. The associated changes in the x-ray beam
characteristics are summarized in Table 3.1. Most of the experiments of
this thesis work have been conducted at the ELETTRA SYRMEP beamline
(SYnchrotron Radiation for MEdical Physics), which is a dedicated beamline
for medical applications. A schematic view of the SYRMEP beamline (BL)
layout is shown in Figure 3.1. The source is one of the ELETTRA bend-
ing magnets. A system of in-vacuum tungsten slits, which shapes the beam
in the desired rectangular dimension is followed by a double silicon [111]
crystals monochromator that permits to select the x-ray energy between 8.5
and 35 keV. Downstream the monochromator, a second system of in-air slits
shapes the monochromatic beam upstream the experimental hutch in which
the beam is used for the experiments.
1 Web site: http://www.elettra.trieste.it
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Table 3.1: The ELETTRA and SYRMEP parameters running at 2.0 and 2.4 GeV.
ELETTRA characteristics
Electron energy 2 - 2.4 GeV
Ring current 300 - 140 mA
Radius 5.5 m
SYRMEP characteristics
Source Bending magnet 1.2 -1.5 T
Critic Energy 3.2 - 5.5 keV
Energy range 8 - 35 keV
Source FWHM ver 100 - 70 µm
Source FWHM hor 870 - 330 µm
Monochromator
Si [111]
Vacuum slits
Air slits
Ionization
chamber
Detector
Bending magnet
Rotational
stage
x-ray
beam
Figure 3.1: A schematic view of the SYRMEP beamline.
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3.1.2 TOMOLAB at ELETTRA
TOMOLAB is a bench top (BT) station at ELETTRA that offers a µ-CT
system based on a microfocus x-ray source.2 Originally it has been designed
for non-destructive investigation in the area of material science, geology or
biomaterials. It permits investigation exploiting the cone beam magnifi-
cation and the maximum spatial resolution, which is achievable with this
system, is determinate by the spot size (5 ÷ 8 µm). A schematic view of the
TOMOLAB is given in Figure 3.2, the x-ray source emits a x-ray cone been
toward the sample that is placed on a rotational stage for the CT measure-
ments. Downstream the sample an x-ray detector collects the transmitted
photons. Some characteristics of the TOMOLAB are summarized in Table
3.2.
Table 3.2: TOMOLAB characteristics.
Parameter Value
Source Hamamatsu L9181S
Voltage 40 ÷ 130 kV
Max current 300 µA
Focal spot size 5 ÷ 8 µm
x-ray
source
Rotational 
stage
Detector
x-ray
cone beam
Figure 3.2: A schematic view of the TOMOLAB station.
2 Web site: http://www.elettra.trieste.it/Labs/TOMOLAB
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3.1.3 SYRMEP vs TOMOLAB
The TOMOLAB has been designed as a complementary instrument to
the SYRMEP BL. Some of the different aspects that are important for x-ray
cell tracking are summarized in Table 3.3. First of all the BL provides a
monochromatic fan beam that permits to tune the most suited energy to
the specific scientific case avoiding beam hardening effects and subsequently
reducing ring artifacts on slices in CT reconstructions. It also permits to
scan the samples over an 180◦ angle respects to a 360◦ rotation in case of
polychromatic cone beams. Regarding the energies range, the BL (8 ÷ 35
keV) is optimized for biomedical studies on soft tissues while the BT (40
÷ 130 kV ≈ 20 ÷ 65 keV) is designed for material science experiments. It
features a polychromatic, isotropic cone beam. The spatial resolution and
subsequently the field of view (FOV) at the BT station can be tuned by
changing the sample-source and detector-source distances. In case of the BL
both parameters are fixed and governed by the imaging detector. The main
limitation of the synchrotron source is its vertical beam size that is limited
to 3 ÷ 5 mm depending on the electron beam energy. As a consequence
plane images of larger samples are obtained by a vertical scan of the sample
through the stationary x-ray beam.
In summary: the TOMOLAB station provide more flexibility regarding
the choice of spatial resolution and the FOV, however, is somewhat limited
in image quality due to polychromatic x-rays. SYRMEP BL is more suited
to optimize the imaging parameters in particular when the x-ray dose must
be kept as low as possible.
Table 3.3: Summary of the major differences between the SYRMEP beamline and the
TOMOLAB station.
SYRMEP TOMOLAB
Beam energy monochromatic polychromatic
Energy range low energies high energies
Beam shape laminar cone
Resolution fixed by detector tunable by magnification
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3.2 The detectors used
As in all imaging applications also x-ray cell tracking relies on suitable
imaging detectors (see also Figure 2.3). An ideal detector should assure:
High quantum efficiency in terms of x-ray conversion into image
information. Ideally all photons eluding the patient should be detected
to avoid additional radiation burden without improving the SNR;
High spatial resolution in term of spatial information which should
be maintained throughout the conversion chain from x-rays to digital
information;
Fast readout time to avoid dead times during fast CT acquisitions and
to increase the through put;
High dynamic range to detect small differences in contrast without
coarse approximations on bit conversion;
Low dark noise to maximize the SNR with a noise floor substantially
smaller than the associated quantum noise.
To date an universal detector that meets all these requirements at a time is
still out of range even though some recent detector developments are very
close to fulfill some of those [66, 67]. In any case detectors used in this
thesis work have been those available at the experimental stations. A list
of these summarizing their main characteristics is given in Table 3.4. For
the ease of reading “nickname” has been assigned to each of the detectors,
which will be used in following. Three of the utilized detectors are Photonic
Science (PS) CCD camera heads with different characteristics. In general
the CCDs work in the visible photon spectra and the x-rays conversion in
light is performed in a coupled scintillators based on phosphor materials.
For instance the 14PhSci detector comprise some exchangeable scintillators
that makes it more flexible for different experiment. The others have a fixed
scintillator optimize for the detector. PICASSO is a single photon counting
(SPC) detector developed in a collaboration between the University of Trieste
and the INFN3 institute [68, 69].
Table 3.4: List of the used x-ray detector at SYRMEP beamline and at TOMOLAB
station and their main characteristics.
Model Type Nick Pixel size FOV Station
[µm2] [mm2]
PS1 CCD 14PhSci 14 × 14 28.7 × 28.7 BL
PS CCD 9PhSci 4.5 × 4.5 17.5 × 11.8 BL
PICASSO SPC2 PICASSO 50 × 300 211.2 × 0.3 BL
PS CCD 25PhSci 12.5 × 12.5 50.1 × 33.4 BT
3 Istituto Nazionale di Fisica Nucleare
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3.2.1 Efficiency
In the following the efficiency of the used detector will be estimated using
some geometrical considerations. The efficiency of the pixel (x, y, t, E) is
defined as:
(x, y, t, E) =
∫
∆t
∫
∆x
∫
∆y
φc(x, y, t, E)dtdxdy∫
∆t
∫
∆x
∫
∆y
φin(x, y, t)dtdxdy
[3.1]
where φin is the incident photon flux (measured in number of photons per
unit area and unit time introduced in Equation 2.6), φc is the converted
photon flux, ∆x and ∆y are the pixel size in x and y directions, ∆t is the
exposure time and E is the photon energy. The Equation 3.1 can be also
interpreted as the number of converted photons per number of incident pho-
tons. φc depends on how the conversion x-ray into signal is performed in the
detector. In general it can be considered:
φc(x, y, t, E) = φin(x, y, t)− φin(x, y, t)e
−
∫
µc(x, y, z, t, E)dz
[3.2]
where µc describes the attenuation coefficient of the active part of the x-
ray converter (e.g. the scintillator). Equation 3.2 shows that the converted
flux is the difference between the incoming flux (φc) and the transmitted
flux (the second term). Considering the x-ray converter constant in time
and homogenous in x and y directions it is possible to remove most of the
dependencies obtaining a more convenient formula:
(E) = 1− e−µc(E)∆c [3.3]
where ∆c is the thickness of the x-ray converter. The energy dependence
has been kept to underline the important relation between the converter
material and the working energy as seen in Equation 2.1. Table 3.5 shows
the expected efficiencies of the detectors used at 24 keV (and aluminum
filtered 50 kV for the TOMOLAB measurement), which is the energy most
often used on our experiments. The CCD detectors presented are coupled
with P43 scintillators (Gd2O2S:Tb) of different thickness that emits a yellow-
green light of 545 nm. PICASSO is instead a 2 mm silicon “edge-on” detector
with a 400 µm non active entrance window.
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Table 3.5: Summary of the expected efficiency of the detector used calculated using the
Equation 3.3 at 24 keV.
Detector Conversion Material Thickness 
[µm] [%]
14PhSci Scintillator P43 20 28.7
14PhSci Scintillator P43 40 49.1
9PhSci Scintillator P43 9 14.1
PICASSO Direct Si 2 000 78.1
25PhSci Scintillator P43 25 34.4
3.2.2 Noise and dynamic range
In a detector noise is the unwanted signal acquired independently by the
source that is added to the information of the signal. It can be physical
noise (for instance cosmic rays or similar), electronic noise (thermal noise of
the electronic components) or random pick-up (not perfect shield of exter-
nal sources). Since the noise is superimposed to the signal it decrease the
quality of the measurement. Another important consequence in presence of
noise is the reduction of the dynamics. Therefore the noise minimizing is
an important part of each measurement and an important characteristic to
evaluate the detectors performances. The commercial detectors are usually
tested and optimized to reduce the noise (e.g. using cooling systems the
thermal noise can be reduced). The dynamic range DR has been calculated
using the definition:
DR =
SM −Do
σDo
[3.4]
where SM is the maximum signal storable, Do is the dark offset and σDo its
standard deviation. The measured Do, σDo (using 1 s of exposure time) and
the calculated DR of the previous mentioned detectors using different pixel
binning are summarized in Table 3.6.
3.2.3 Spatial resolution
Another crucial characteristic of an imaging system is the spatial resolu-
tion that is the capability to spatially resolve details. The resolution is often
confused with the detector pixel size. This detector parameter, however,
does not take into consideration the resolution degradation caused e.g. by
the source size, the information spread generated inside the x-ray converter
or the cross-talk between neighbor pixels. For that reasons it is necessary to
refer to a “imaging system resolution” taking into account all the processes
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Table 3.6: Summary of the noise measurements on the detector used changing the pixel
binning with the exposure time of 1 s.
Detector Binning SM Do σDo DR
(pixel [µm])
14PhSci 1 [14] 216 753 15 4319
14PhSci 2 [28] 216 861 16 4042
14PhSci 4 [56] 216 1321 18 3568
9PhSci 1 [4.5] 212 96.0 0.8 5000.0
9PhSci 2 [9] 212 128.1 0.9 4408.8
9PhSci 3 [13.5] 212 294.1 1.1 3456.3
9PhSci 6 [27] 212 282.0 0.9 4237.8
9PhSci 8 [36] 212 342.2 0.9 4170.9
PICASSO 1 [50] 224 1.0 0.2 8 × 107
25PhSci 1 [12.5] 212 96.0 0.7 5714.3
25PhSci 2 [25] 212 95.7 0.7 5714.7
from the source to the final image that take part on the final capability of
spatially resolve the image details. This is usually done measuring the sys-
tem Point Spread Function (PSF) that is the response of an imaging system
to a pointlike stimulus signal [70]:
PSF (x, y) = Σ[δ(x, y)] [3.5]
where δ(x, y) is the so-called δ-Dirac function and Σ is an operator (supposed
to be linear and invariant for translation on x and y axes) that mathemati-
cally describes all the transformations-degradation of the image information
within the image creation chain. In general it is not necessary to recover
the operator Σ and it is commonly accepted to quote the Full Width of Half
Maximum (FWHM) of the measured PSF as an indicator of the imaging
system resolution. To access the imaging resolution of the detectors utilized,
their PSFs have been measured in or close to the imaging configurations
used within the imaging experiments (except PICASSO, the values refers to
a beam energy of 24 keV at BL and at 50 kV - 150 µA at BT). Where pos-
sible, the Fujita method witch exploits oversampling has been applied [71]
otherwise the common methods has been used. On the CCD measurements
the isotropic PSF response has been assumed as demonstrated by [72].
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Table 3.7: Summary of the PSF measurements on the detector used changing the pixel
binning at 24 keV.
Detector Thickness Binning FWHM-PSF
[µm] (pixel [µm]) [µm]
14PhSci 40 1 [14] 62 ± 2
14PhSci 40 2 [28] 78 ± 2
14PhSci 40 4 [56] 117 ± 2
14PhSci 20 1 [14] 34 ± 2
14PhSci 20 2 [28] 42 ± 2
14PhSci 20 4 [56] 60 ± 2
9PhSci 9 1 [4.5] 12.0 ± 0.7
9PhSci 9 2 [9] 20 ± 2
9PhSci 9 3 [13.5] 26 ± 2
9PhSci 9 6 [27] 43.8 ± 1.0
9PhSci 9 8 [36] 56 ± 4
PICASSO* 2 000 1 [50] 50 ± 3
25PhSci 25 1 [12.5] 59 ± 4
25PhSci 25 2 [25] 78 ± 3
* measured by [68] at 19 keV.
3.3 Discussion
The characteristic of the instrumentation available at the x-ray stations
in Trieste have been presented. A particular attention has been dedicated for
the detector characterization in the experimental setting used throughout the
thesis. The efficiency of the x-ray conversion at 24 keV (the energy mostly
used of the experiment) is ranging from 14 % of the 9PhSci CCD detector
to 78 % of the silicon PICASSO detector. The latter has the drawback to
acquire only one slice per turn. The noise measurements divided by the
saturation value has found again the PICASSO detector as the best one,
because of its very low noise and the unlimited dynamic. On the resolution
side, the CCDs detectors offer a better choice to obtain higher resolution with
respect to PICASSO. Thanks to the thinner scintillator and the smaller pixel
size, the 9PhSci CCD got the best resolution of ∼ 12 µm. A factor of two in
resolution has been measured on the 14PhSci CCD changing the scintillator
screen from 20 µm thickness to 40 µm as expected. On the other hand the
thicker scintillator permits an improvement of a factor of 1.7 in efficiency.
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Chapter 4
Cell procedures
In Chapter 2 imaging properties of x-rays as well as common x-ray con-
trast agents have been presented. It has been pointed out that gold NPs are
in principle good candidates as cellular marker for x-ray cell tracking. In the
following chapter a procedure to load cells with gold NPs will be presented.
Growth measurements will indicate if the marker chosen fulfill the require-
ments introduced in Chapter 1, namely to be a suitable contrast agent for
cell tracking that should be: biocompatible, safe and nontoxic, inert for cell,
and stable incorporated into the cells over long time. Moreover, it should not
dilute (or only minimally dilute) with cell division and should not transfer
the marker to other non-labeled cells [2]. The amount of NPs per cells will
be elucidate using mass spectroscopy and the effective internalization of the
NPs will be measured using transmission electron microscopy (TEM) and
scanning electron microscopy (SEM).
4.1 Cell loading and grow
4.1.1 Loading cultured cells with colloidal gold
Colloidal gold nano particles (∼ 50 nm diameter) were prepared as out-
lined in [73]. In brief, 400 ml of 0.01% HAuCl4 were boiled for 5 minutes,
after which 4.0 ml of 1% sodium citrate were quickly added. The fluid was
kept boiling for 30 more minutes, during which time the previously colorless
fluid changed color over dark blue to a dark red. The fluid was then allowed
to cool on ice after which 3 ml sterile potassium carbonate (K2CO3) were
added, resulting in a pH 6.5. Following this, 1 ml dialyzed horse serum was
slowly added. The solution was then centrifuged at 15 000 g for 45 minutes,
after which the supernatant was aspirated and the pellet re-suspended in
400 ml sterile water. The new suspension was again centrifuged at 15 000
g, this time for 20 minutes. The resulting pellet was re-suspended in 20 ml
Dulbecco’s modified Eagle’s medium (DMEM) containing 5% horse serum
to form a gold NP stock. Mass spectroscopy was used to establish a con-
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centration of about 464 µg/ml of elemental gold. The gold stock was frozen
in aliquots for subsequent use. C6 glioma cells (ATCC, U.S.A.), hMSCs
(human Mesenchymal Stem Cell, StemCell Technologies Inc., Vancouver,
Canada) and OECs (Olfactory Ensheathing Cell, generated from the outer
nerve layers of day 14 Wistar rat embryos) were grown in 100 mm tissue cul-
ture dishes until they were about 70% confluent in a humidified incubator
with 5% CO2 at 37◦C. To each 100 mm culture dish containing a total of 8
ml medium, 1 ml of gold stock was added. This brought the concentration
of elemental gold in the growth medium to 51.9 µg/ml. Cultures were har-
vested 22 hr later. In order to determine how much of the elemental gold had
actually been taken up by the cells, we submitted 3 samples of gold-loaded
cells as well as naïve control samples for each cell line, containing 107 cells
each, for mass spectroscopy. The average uptake of gold in 107 cells after
22 hrs exposure to 52 µg/ml gold in the growth medium was 335 ± 3 µg
for C6 glioma cells, 332 ± 2 µg for hMSC and 357 ± 55 µg for OEC (see
Figure 4.1) yielding for example a cellular gold density of 0.037 g/cm3 for
the C6 cells prior mitosis. It translates in ≈ 26 500 NPs per cell. The dif-
ferences in the group averages of gold uptake between the different cell lines
were statistically not significant (unpaired t-test). The confidence values (p-
values) can be quoted with: C6 versus hMSC: 0.304; C6 versus OEC: 0.522;
hMSC versus OEC: 0.479. No gold NPs were detected in the naïve control
cells. The image in Figure 4.2 shown a cell many days after the gold uptake
at TEM. Many of the individual gold NPs have fused inside the lysosomes.
Note many of the individual NP seem to have fused into one single mass as
a cluster of NPs. From the lysosomes filled with distinguishable individual
particles (inlet), the size of the gold NPs can be confirmed in a diameter of
about 50 nm. [74]
4.1.2 Growth assays
To assess whether the incorporated gold affected the proliferation rate
of the cells, we conducted growth assays with all three cell lines. For each
cell line, six 100 mm culture dishes were seeded with an equal number of
cells. On day three after seeding, 1 ml of colloidal gold stock (containing
about 464 µg/ml of elemental gold) was added to the cell culture medium in
half of the dishes, bringing the concentration of elemental gold in the growth
medium to about 51.9 µg/ml. The gold-containing medium was removed
22 hrs later and fresh growth medium was added. Cells were counted on
days 2, 4 and 6 after gold exposure and numbers were compared with those
in the dishes not exposed to colloidal gold in the medium showing that our
loading protocol has no significant statistic effects on cell proliferation at any
time point (Figure 4.3). The p-values for the comparison between naïve and
gold-loaded cells on day 6 after exposure were p = 0.977 for C6 glioma, p =
0.927 for hMSC and p = 0.315 for OEC.
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Figure 4.1: Measurement of the cellular gold uptake for different kind of cells (C6, OEC
and hMSC) using mass spectroscopy.
Figure 4.2: Transmission Electron Microscopy of a cell many days following gold uptake
showing parts of the nucleus and in its vicinity mitochondria and lysosomes. Individual
gold nano particles have fused inside the lysosomes.
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Figure 4.3: The growth assays using naïve cells and gold-loaded cells revealed that the
loading protocol has no significant effects on cell proliferation in all the kind of cells tested.
4.2 SEM cell measurements
The gold loaded C6 cells have been studied using the Scanning Elec-
tron Microscopy SEM ZEISS SUPRA 40 available at the TASC laboratories
(Tecnologie Avanzate e nanoSCienza, Basovizza, Trieste, Italy).
4.2.1 Samples preparation
The SEM slides have been prepared starting from microscope cover glass
22 x 22 mm2 No.2 of thickness (Thermo scientific). The slides were previously
oxidized with a substrate of Indium Tin Oxide (ITO), to permit a good
conductivity essential for SEM measurements. The slide were wiped with
70% alcohol and placed on the bottom of cell culture well plate; 0.1 ml of
medium containing about 50 000 cells were dropped onto the slides with 2 ml
of culture medium (DMEM + 10% FBS + 15 mM Glucose); then the slides
were placed into an incubator overnight (5% CO2, 37◦C). The day after the
growth medium was aspirated and a mixture of 4% Paraformaldehyde (PFA)
and 0.5% glutaraldehyde was added and warmed up to 37◦C in a water bath
for 25 min. This part is important for good fixation and to keep the shape of
the cells. Afterward the slides were rinsed with Phosphate-Buffered Saline
(PBS) 1× and 3× for 5 minutes each. The dehydration was performed
adding 50-70-90% alcohol for 30 min each and then adding 100% alcohol 3
× 30 minutes. Eventually an air dry process was applied.
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4.2.2 Cells visualization
The Figure 4.4(a) shows a C6 cell obtained at the SEM using a voltage
of 10 kV. The typical “star” shape of the C6 cell is recognizable. The gold
NPs are also well visible in the cell area. It is noticeable that the NPs
are organized in clusters of various dimensions (as seen in the TEM image
in Figure 4.2). Figure 4.4(b) shows one of the NPs clusters with higher
magnification.
10 μm
(a)
500 nm
(b)
Figure 4.4: SEM image of a gold loaded C6 cell with its typically “star” shape with long
arms (a). The gold NPs (white spots) are well visible. Higher magnification reveals that
the NPs build cluster inside the cells (b).
From the images in Figure 4.4 it is not clear if the NPs are aggregated on
cell surface (membrane) or are accumulated inside the cytoplast. To clarify
this point a different electron acceleration voltages have been applied on the
same cell obtaining the images depicted in Figure 4.5. At higher voltage the
electrons have higher kinetic energy and subsequently penetrate deeper into
the cell surface as in Figure 4.5(a); On the contrary the lower voltages results
in a suitable kinetic energy of the electrons to investigate only the surface
(membrane) of the cell as shown in Figure 4.5(d). Figure 4.5(a) shows also
that the voltage is not high enough to visualize all the NPs clusters because
some of them are located too deep and are visible just as a white shadow
within the cell. In this way it has been demonstrated the internalization of
the gold NPs inside the cell.
4.2.3 Estimation of the number of nanoparticles
Due to the high resolution provided by the SEM it is possible to roughly
estimate the number of NPs present within the cells. Since this is a long work
that needs a lot of patience it has been carried out only once for one cell
to demonstrate its feasibility. The ImageJ1 plug-in Cell Counter has been
1 web site: http://rsb.info.nih.gov/ij/
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(a)
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(b)
2 μm
(c)
2 μm
(d)
Figure 4.5: SEM image of a gold loaded C6 cell changing the electron acceleration
voltages: 15 kV (a); 10 kV (b); 5 kV (c); 2 kV (d).
used to count the clusters of gold NPs inside the cell. The procedure has
been applied to the image shown in Figures 4.5(a) and a second image of the
same cell with lower magnification in which almost the entire cell is visible
in Figure 4.6(a). The latter shows a coarse estimation of the NPs clusters
counted in the entire cell. Depicted in Figure 4.6(b) are those clusters marked
in blue that were identified already in the low resolution image. Due to the
higher resolution additional clusters could be identified which are identified
in light blue. Summing up the different clusters resulted in a total number
of 108 clusters. The previous number is an estimation since the clusters
(a) (b)
Figure 4.6: NPs cluster counted in a C6 cell using the ImageJ plug-in Cell Counter on
a SEM image.
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feature different spatial extensions. Moreover they can be superimposed or
too deep to be recognized. The second step to estimate the number of NPs is
the measurement of the mean diameter of the clusters counted which can be
quoted as ∼ 320 nm as the cluster depicted in Figure 4.7(a). An estimation of
the number of NPs per cluster can be obtained using Vcl/VNP ×fP where Vcl
is the cluster volume, VNP the NPs volume and fP the packing factor. For
a body-centered cubic structure fP ∼ 0.68. In our case, taking as reference
the Figures 4.7(a) and 4.4(a) we estimate a fP ∼ 0.4 ÷ 0.5 resulting in ∼
105 ÷ 130 NPs/cluster. The counting of the NPs in the 320 nm diameter
cluster shown in Figure 4.7 results in 27 NPs. In our estimation it means
that a factor ∼ 3.8 ÷ 4.8 of the NPs is hidden in the 2D image. Taking
(a) (b)
Figure 4.7: SEM image of a NPs cluster inside the cell under exam. The cluster has a
mean diameter of 320 nm and it has been used to estimate the mean number of NPs per
cluster.
in account all the aforementioned assumptions the NPs number in the cell
is estimated to be 12 700 ± 1 400. This value is probably underestimated
since NPs cluster located in deeper layers of the cell were invisible in the
SEM and subsequently have not taking into account. Keeping in mind that
the cells fixation has been performed 22 hours after the loading process and
the doubling time for C6 cells is approximately ∼ 48 hours, this result is
compatible with the mass spectroscopy measurement if the cells underwent
one mitosis process.
4.2.4 Are the NPs equally divided during mitosis?
The question of the partition of the contrast agent raised in this section
is extremely important for all cell tracking techniques that use exogenous
contrast agents. A non-partition means that only the initial injected cells will
be identifiable and thus the system is not suited for long term cell tracking.
Therefore, if the goal is to investigate the fate of the cells throughout several
cell generations a partition of the contrast agent will be needed. To clarify
the partition issues in details deeper investigation of these phenomena have
to be performed. In the following a SEM image of a C6 cells a during
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probable mitosis is presented (Figure 4.8) where the gold NPs clusters appear
in both cells (may be not in perfect equipartition). Note that during the
mitosis process the C6 cells change size and shape: They become more round
and smaller. This image does not represent a definitive discover or exact
measurement but gives an indication of the partition of the contrast agent.
5 μm
Figure 4.8: SEM image of to C6 cells fixed during the mitosis. The gold NPs cluster are
visible in both cells.
4.3 Visibility estimation for gold loaded cells
In the previous Section important aspects of the cell loading protocol have
been demonstrated that permits to mark the cells for x-ray measurements.
First the gold amount into the cells has been measured for different kind of
cells, second the cell grow have been demonstrated independent by the NPs
presence, third the internalization of the NPs has been confirmed by SEM
measurements as well as an indication of the partition of the NPs during the
mitosis has been obtained (Figure 4.8). In the following all of these points
will be used to estimate the applicability of a cell tracking technique based
on x-ray CT and the gold loading process presented. [74]
4.3.1 Gold loaded cells attenuation coefficient
It is possible to calculate the cells visibility starting from the mass spec-
troscopy data. In the following we will calculate it for C6 tumor cells. We
approximate the cells as sphere containing a gold amount (or a certain num-
ber of gold NPs) distributed uniformly over the cell volume. In our model we
assume a C6 cell in spherical approximation. This is a rough estimation on
a scale lower than 1 µm but enough precise on our x-ray imaging resolution
(1.5 ÷ 50 µm). We measured cell extensions based upon photographing C6
cells in a hemocytometer and then measuring diameters taking into account
the fringes effects. Twenty-five spherical cells measured exhibited a mean
diameter of w = 12 ± 2 µm. The measured diameters ranged from 10 to
16 µm. The 10 micrometers likely being cells in G1 and the 16 µm possibly
being binucleate cells. On the basis of these findings the mean volume/cell
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was calculated to be ∼ 900 µm3 or just below 1 pl. As we have seen, mass
spectroscopy we carried out on our cell cultures revealed that on average
335 ± 3 µg of gold was taken up per 107 C6 cells yielding together with the
measured cell volume a maximum cellular gold density of 0.037 g/cm3. This
translates into ∼ 26 500 gold nano particles featuring an average diameter
∅ = 50 nm per cell. This number was confirmed in Section 4.2.3 analyzing
SEM images. Loaded with gold, in first approximation the cells can be con-
sidered as a mixture of gold and cell material that is very close to a mixture
of water and some minerals.
Because of the gold a loaded cell increase its original density (ρcell =
1.04 g/cm3) and becomes ρgoldcell = 1.075 g/cm
3 which subsequently results in
weight fractions Wgold = 0.034 and Wcell= 0.966 for gold and cell, respec-
tively. With the latter we can calculate the effective absorption coefficient
µw of the gold loaded cell as to:
µw(E) =
[(
µ(E)
ρ
)
gold
Wgold +
(
µ(E)
ρ
)
cell
Wcell
]
ρgoldcell [4.1]
Figure 4.9 shows the µw, µbrain and µbone as function of the photon energy
(E). A good energy to retrieve the position of C6 cells inside the brain must
maximize the difference between µw and µbrain that is highest between 12-
17 keV. However, at the same time at these energies absorption of bone is
very high. Therefore another energy window for cell tracking in the brain
studies should be considered around 21 keV and greater. This has been
also motivated taking in account that at lower energy the dose is higher.
Certainly for in vivo measurements the dose requirements are stringent and
the x-ray energy should range between 21 and 25 keV.
4.4 Discussion
In the previous chapters the importance of finding a good x-ray cellu-
lar marker that fits perfectly on the imaging technique characteristics has
been discussed. In this Chapter a procedure for marking different kind of
cells (C6, hMSC and OEC) with gold NPs has been presented. The amount
of gold NPs (with a diameter of ∼ 50 nm) per cells has been measured
with mass spectroscopy resulting in ∼ 26 500 NPs/cell without significant
differences between different cells lines (of malignant and non malignant na-
ture). Measuring the cell proliferation on gold loaded cells and naïve cells no
statistically relevant differences have been found confirming a good cellular
tolerance of the marker. SEM measurements have confirmed the presence of
the gold NPs inside the cell cytoplast as expected. The measured number
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Figure 4.9: Linear attenuation coefficients of the gold loaded cells (result of the mass
spectroscopy) in function of the x-ray energy (continue line) compared to the linear at-
tenuation coefficients of brain (broken line) and bone (dotted line).
of NPs is within the error-bars compatible with the mass spectroscopy mea-
surement. A single SEM image of a C6 cells during the mitosis has shown
a partition of the contrast agent between the daughter cells. On the basis
of these measurements an estimation of the cellular contrast using x-ray CT
has been carried out confirming the possibility to visualize gold loaded cells
due to the presents of the NPs. For in vitro measurements the best energy
to visualize the gold loaded cells is 12 keV that becomes higher for ex vivo
and in vivo measurements. For example, the best energy for a marked brain
tumor study is between 20-25 keV because of the presence of the skull that
is a strong absorber for the lower x-ray energies. In the next chapters the
visualization of the marked cells will be presented.
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Chapter 5
High resolution in vitro cell
tracking
In the previous chapters it has been shown that gold NPs are a suitable
contrast agent for x-ray imaging. A cell loading procedure for different kind
of cells has been presented demonstrating that the amount of gold per cell
can be adequately high to provide a sufficient contrast without interfering
with cell functioning and cell proliferation. It this Chapter, the first in vitro
measurements of gold loaded cells will be presented and discussed using
different x-ray imaging set ups and configurations trying to obtain the best
resolution possible with the instrumentation used.
5.1 Samples description
The samples use in this experiment consisted in Eppendorf tubes (0.6 ml)
containing gold loaded C6 glioma cells suspended in 5% gel agarose (BioRad
Laboratories) as depicted in Figure 5.1. Agarose gel permits to keep the cells
stationary and at the same time isotropically distributed in the 3D space.
The cell loading procedure applied was the one described in Section 4.1. The
agarose was autoclaved and immediately placed into an 80◦C water bath to
maintain fluidity. Cellular pellets were resuspended in agarose in different
concentration of cells from 400 000 to 10 cells on ∼ 0.2 ml of agarose gel.
Because of the higher concentration the 400 000 and the 200 000 samples
have been used most. For instance the former provides in average one cell
within each cubic voxel of ∼ 80 µm side).
C6 cells have shown a mean diameter of ∼ 12 µm (as measured in vitro
in Section 4.3) therefore a mean resolution (12 ÷ 60 µm) permits the visu-
alization of clusters gold loaded cell only. Increasing the resolution (2 ÷ 11
µm), a single cell can be accessible. Continuing on scaling the resolution (6
1 µm) the cluster of NPs should be visible inside the cell.
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gold loaded C6 cellsagarose gel 5%
Figure 5.1: Figurative scheme of the samples preparation. The C6 cells are marked
with gold NPs separately in a Petri dish then they are embedded in agarose gel at 5% of
concentration. A mixture of gold loaded cells and agarose gel is finally poured into a 0.6
ml Eppendorf tube.
5.2 Preliminary measurements at CLS
Preliminary measurements were performed at the BMIT beamline at
Canadian Light Source during a three month visiting period1. The CLS and
the BMIT beamline properties are summarized in Table 5.1. During the
experiments only the bending magnet BL was available. CT data has been
acquired using the Hamamatsu C4742-98 ERG CCD detector coupled to a
Hamamatsu AA40 scintillator unit2. This detector configuration provides
an effective pixel size of 10 µm with a maximum signal of 214 counts. The
number of projections was 943 and the duration of a CT scan took around
40 minutes. The energy used was 20 keV and the software use for the recon-
struction was the STP. Briefly, STP (Syrmep Tomo Project) is an in-house
software developed at the SYRMEP beamline at ELETTRA. It is based
on an IDL code providing the graphic user interface (GUI) and integrates
some C routines for fast filtered backprojection. Originally developed for the
SYRMEP beamline experimental case it uses the parallel beam approxima-
tion. Therefore it can be also used with generic CT data acquired at long
beamlines, such as SYRMEP or BMIT. The STP software has been used in
most the experiments presented in this work.
1 BMIT is the Biomedical Imaging and Theraphy beamline at the CLS, the canadian
synchrotron in Saskatoon (Saskatchewan, Canada). Web site: http://www.lightsource.ca/
2 Web site: http://www.hamamatsu.com/
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Table 5.1: The CLS and BMIT beamlines parameters.
CLS & BMIT-BM characteristics
Electron energy 2.9 GeV
Ring current 500 mA
Radius 27 m
Source 1.354 T Bending magnet
Critical Energy 7.57 keV
Energy Range 8 ÷ 40 keV
Beam size 231 mm × 4.6 mm @ 23 m
Imaging parameters
Energy 20 keV
Pixel size 10 µm
FOV 13.4 × 2 mm2
Exposure time 2.4 s
No. projections 943
5.2.1 Results
In Figure 5.2 a reconstructed Maximum Intensity Projection3 (MIP) CT
slice of the sample with 400 000 marked cells is shown. The depicted slice
has been assembled using a the MIP procedure over 20 slices resulting in
a total of 200 µm thickness. It helps the 2D visualization of absorbed de-
tails isotropically distributed over a thin volume. An accumulation of gold
indicated by the distribution of white spots is clearly visible inside the Ep-
pendorf container. This implies that the cells aggregate locally enough gold
NPs to permit their visualization against the background utilizing detec-
tors featuring a pixel size of tenths µm (PSF ∼ 20 ÷ 30 µm). Besides some
larger and brighter spots are visible as well. These can be interpreted as cells
clusters that present higher absorption properties. While cells clusters are
certainly recognizable single cells are barely visible due to the limited spatial
resolution of the detector used. Single cells are hardly separable from the
background noise. The effect of a PSF larger than the size of the detail under
investigation is known as undersampling [75]. This means that the spatial
information is spread over a substantial larger volume than the effective de-
tail volume. Consequently the object appears larger and subsequently its
contrast appears lower. This effect is shown in Figure 5.2(b), where higher
magnification was used. While in this configuration spots stemming from
C6 cell clusters are clearly visible the weak -and spatially smeared- signal of
single cells is hardly distinguishable from the background.
3 MIP projects on each pixels of a single 2D image the maximum value over a desired
stack of images.
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2 mm
(a)
200 μm
(b)
Figure 5.2: (a) Reconstructed x-ray CT MIP image of the sample containing marked
C6 cell in agarose gel over 20 slices. The smaller and barely visible white spots are single
gold loaded cells while the clearly visible spots are cell clusters of the marked cells. The
green square indicate the area of the zoom shown in (b). The four bigger spots are cluster
of cells and the smaller ones are signals of single cells smeared by the system PSF.
5.3 Higher resolution at SYRMEP
In the previous section it has been shown that the resolution provided at
the CLS which is comparable to that of the SYRMEP beamline and in the
order of > 10 µm permits to visualize correctly clusters of gold loaded cell.
In order to visualize single cells it would require higher spatial resolution.
One way to increase the resolution of a detection system is the use of a
system of magnifying optic lenses, thus a microscope. Such a lens system
works with visible light only. Therefore it requires also a scintillator that
converts x-rays into optical photons, which form a virtual image in the plane
of the scintillator. This virtual image is observed with the microscope and
magnified images are obtained according to the lens system used. The main
problem of this method is represented by the scintillator that should be very
thin to avoid physical spread of the light during the internal path which
subsequently increases the FWHM of the PSF. According to Equation 3.3
thin scintillators are less efficient. Moreover, the lens system is less efficient
compared to the fiber optic coupling used for example at SYRMEP beamline.
Due to the limited efficiency optical magnification is mainly used at higher
flux beamlines. For example at Swiss Light Source (SLS) in Switzerland
[76], at Advance Photon Source in USA, at European Synchrotron Radiation
Facility in France or at Spring-8 in Japan. Here the lower efficiency of the
detector in balanced with the higher input signal. Direct tapered systems
are preferable at lower flux beamlines such as SYRMEP or BMIT-BM.
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Another method to increase the spatial resolution of imaging devices
based on common CCD detectors (with resolutions > 10 µm) is using magni-
fication systems before the x-ray conversion. The so-called “bragg magnifier”
uses a coupled set of asymmetrical cut crystals in orthogonal configuration
to magnify the x-ray beam downstream the sample on both the image di-
rections [77–79]. A general scheme of the “bragg magnifier” is presented in
detector
II crystal
I crystal
x-ray
beam
Figure 5.3: The “bragg magnifier” setup consists in two asymmetrical cut crystals that
diffract and magnify the beam in each direction. Placing the crystals perpendicular one
to each other the final result is an isotropic magnification in the image plane.
Figure 5.3. The incident beam impinges on the first crystal, which diffracts it
in the horizontal plane thus magnifying the image in the horizontal direction.
Subsequently, the diffracted beam reaches the second crystal and diffracts
on the vertical direction thus magnifying the image also on the vertical di-
rection. The combination of the two magnifications provides an isotropic
magnification in the image plane. Such a system could be used to image
gold loaded single cells.
5.3.1 Bragg magnifier setup
For this an experiment was designed to obtain an effective pixel size
around 1 µm using the 9PhSci detector available at SYRMEP beamline and
described in Section 3.2. The smaller effective pixel size in combination with
a fixed number of pixels results in a reduction of the FOV, which has some
impact on the CT acquisition mode as discussed below. The magnification
follows the equation:
m =
sin (θB + α)
sin (θB − α) [5.1]
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where m is the magnification factor, θB is the bragg angle and α is the
crystals asymmetric cut. It was decided to use a couple of silicon [111] crystal
with a 7◦ asymmetric angle that at 12 keV provide a magnification factor
(m) of 6.5 in both direction and subsequently a nominal pixel size of ∼ 1.4
µm if working in a binning 2 mode. Due to time constrain the pixel binning
was mandatory. The FOV reduces to ∼ 2.5 × 2.5 mm2 that is smaller than
the sample size. All the experiment parameters are reported in Table 5.2. To
avoid the option of removing part of the agarose gel from the tube (with other
words to damage the sample), Local Tomography (LT) has been applied. In
LT only a local portion of the sample is imaged thus an incomplete data set
is acquired. [80–82] In this way it is possible to increase the resolution in a
specific volume of interest (VOI) of the sample. However, the drawback of
LT is a general decrease in the quality of the reconstructed CT slices due
to limited image normalization during the backprojection process. In LT
the VOI has placed in the center of rotation. A proper alignment usually
requires a first full FOV scan before the LT can be applied. In our case the
sample isotropy permits to waive the FOV scan since the cells are equally
distributed within the entire volume.
Table 5.2: “Bragg Magnifier” experiment parameters.
Parameter Value
Energy 12 keV
Crystals Si [111]; α = 7◦
θB 9.5◦
m 6.5
effective pixel 1.4 µm
System PSF 4.70 ± 0.17 µm
FOV 2.5 × 2.5 mm2
No. projections 1 200
Exposure time 22 s
Total scan time 7h 20min
5.3.2 Results and data analysis
Some representative results of the bragg magnifier experiments are shown
in Figure 5.4(a), where a reconstructed slice of the sample is reported. Each
of the white spots represents a single C6 cell. Due to the higher resolution
the single cells can be distinguished from the noisy background and deeper
investigations such as segmentation and cell counting can be applied as dis-
cussed further down. Figure 5.4(b) reports a 3D rendering of two cells.
The measured PSF of the system is 4.7 µm causing blurring effect in the
vicinity of the cells, which are visible in Figure 5.4(b). As a consequence the
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50 μm
(a)
10 μm
(b)
Figure 5.4: Reconstructed CT slice obtained at SYRMEP beamline using the “bragg
magnifier” setup that provide a monochromatic beam at higher resolution. (a) In the slice
the white spots are identified as single C6 cells. (b) 3D rendering of two C6 cells. The
images are obtained using the software OsiriX.
resolution is not sufficient to visualize the NPs cluster inside the cells. Also
for this reason, the C6 cells appears homogeneous spherical objects with a
mean diameter of ∼ 10 µm. The cells are smaller respect to the measure
presented in Section 4.3 because this time they have been measured in 3D
and not in a 2D plate where the cells slightly spread its volume.
As mentioned above, the resolution is sufficiently high to distinguish
each single cell and to extract some quantitative data. As a demonstration a
VOI has been used to measure the cells volume distribution. The BLOB3D
software [83] has been used for all the data mining. The software works in two
steps, firstly it applies segmentation and secondarily it analyses those objects
that were found in the previous step. For the segmentation the function
“Seeded GS Range” has been used. It uses a seed threshold to recognize
voxels that are for sure part of the objects under exam. Starting from that
voxels the algorithm grows the segmentations evaluating the adjacent voxels
that must feature values greater than a second lower threshold to be part
of the segmented volume. The seed threshold has been chosen manually
to be high enough to identify real cells rather than counting noise, even at
the risk of loosing cells with lower absorption properties. Then the Regions
of Interest (ROIs) have been counted and the volume has been measured.
It is notable that the choice of the lower threshold for a constant seed can
change the final volume of the cells. The lower the threshold the larger the
volumes. At higher thresholds only the cores of the cells are considered.
In Figure 5.5 the reconstructed slices a cell (Figure 5.5(a)) is segmented
using different thresholds. As mentioned above, the high threshold in Figure
5.5(b) segments only the central part of the cell, while using lower thresholds,
the ROI tends to smear out. Therefore, the algorithm interprets two or
more cells as a single one, decreasing the counting statistics as shown in
67
- High resolution in vitro cell tracking -
Figure 5.5(d). While in the former case the ROI is underestimated thus
the threshold was chosen too high in the latter it is obviously overestimated
and therefore the threshold was too low. To avoid this arbitrariness and
minimize the error, a threshold scan has been executed at constant seed
and the following iterative method was applied. Starting from a reasonable
threshold (as shown in Figure 5.5(c)) equidistant from the two extremes a
threshold scan in an interval equivalent to twice the background noise was
performed. This interval was subdivided into ten thresholds and for each of
this threshold a segmentation of all the cells within the entire volume was
performed. The cell volumes which have been found in this fashion were
stored in a histogram with constant binning. Eventually the ten histograms
were bin-wise averaged as shown in Figure 5.6 where the error bars is the
standard deviation of the mean value for each bin.
20 μm
(a) (b)
(c) (d)
Figure 5.5: Example of what happens using different thresholds on the cell volume
calculation. The cell slice is shown in (a) and in (b) the segmented part of the cell is
shown in yellow using a high threshold. In this case part of the cell is missed. In (c-d)
lower thresholds are used. Using a low threshold (d) background noise is accumulated.
The graph in Figure 5.6 shows the histogram of the cell volume measured
from the VOI. The bin width is 72 µm3 to have a significant statistics in
the main part of the histogram. A bell shaped distribution is shown cen-
tered around 500 µm3 that corresponds to a mean diameter of 10 ± 4 µm
(assuming the cells as perfect spheres).
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Figure 5.6: Histogram of the measured cell volume on a sub volume of interest.
5.4 High resolution using a µ-focus x-ray source
In the previous section have been discussed the possibility to visualize
single cells in vitro using synchrotron radiation. In the following section
the same experiment has been carried out at the TOMOLAB facility at
ELETTRA using a conventional µ-focus x-ray tube. Due to the cone beam
geometry with the latter it is possible to obtain high magnifications. On the
other hand, placing the detector far from the source decreases the photon
flux, which results in long acquisition times, if a certain counting statistics
is required. In this experiment a magnification of six has been chosen which
results in a system resolution comparable to the size of the C6 cells under
exam. A limit of the instrumentation used is the x-ray focal spot that is in
the range of 5 ÷ 8 µm depending on the tube power. The finite source size
adds a blur effect on the final system resolution (penumbra effect) which can
be quoted as to ∼ 16 µm. The imaging parameters used in the TOMOLAB
experiments are summarized in Table 5.3.
5.4.1 Results and data analysis
The result of the experiment can be summarized with the help of the
reconstructed sample slice in Figure 5.7. As in the synchrotron experiments
clusters of marked C6 cells are clearly visible but also single cells are present
although less pronounced (see Figure 5.7). As background noise is present it
can be confused with real cells (smaller spots in the image) which is again an
effect due to the undersampling that smears out a single C6 cells of ∼ 10 µm
in a volume of ∼ 7 voxels. To underline the difference in resolution between
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Table 5.3: TOMOLAB experiment parameters.
Parameter Value
Voltage 50 kV
Current 150 µA
Filters 0.5 mm Al
Source-Sample distance 9 cm
Source-Detector distance 54 cm
Magnification factor 6
Binning 2
Pixel depth 12 bit
Effective pixel size 4.17 µm
System PSF 15.7 ± 0.5 µm
Exposure time 13 s
No. projections 1440
Total time 5 h 12 min
FOV 49.9 × 33.2 mm2
50 μm
Figure 5.7: Reconstructed CT slice obtained at TOMOLAB facility using a high resolu-
tion configuration. In the slice the larger white spots are small clusters of C6 cells and the
smaller spots are barely visible single cells and background noise that reduce in addition
the capability to recognize them.
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the TOMOLAB and SYRMEP measurements, Figure 5.8 shows a slice of a
single cell (not exactly the same cell) reconstructed from data acquired using
both methods, Figure 5.8(a) and 5.8(b) respectively. Now the question is:
20 μm
(a)
20 μm
(b)
Figure 5.8: Comparison of a reconstructed single cell slice. Data was acquired at the
TOMOLAB facility with lower resolution (a) and the SYRMEP beamline (b).
is it possible to measure the cell volume also from the data acquired at the
TOMOLAB? To answer this question the same procedure has been applied
on a similar VOI using the same criteria (seed value high enough for the
segmentation and variable lower thresholds to evaluate the bin errors). At
a first glance the method generates an exponential shaped histogram ap-
parently without further information because of the high background noise
present in the reconstructed data (Figure 5.9). Under the frame condition
that the noise has not a preferential shape but just a random one, a shape
filter has been applied on the measured ROIs obtaining the histogram dis-
tribution shown in gray in Figure 5.9. This distribution is similar to the one
obtained using higher spatial resolution provided at the SYRMEP beamline
(Figure 5.6) proving that the same objects have been measured. Moreover
using this BT method the uncertainty on single cell volume is higher since
the voxel size is greater than the one of the BL. This effect is not visible
in the histograms because the width of the cell volume distribution is dom-
inated by the fluctuations of the cell size that is greater than the minimum
bin width corresponding the voxel size. On the other hand, the method
has demonstrated the feasibility to measure the cell volume distribution also
using a conventional x-ray µ-focus tube.
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Figure 5.9: Histogram of the measured cells volume on a sub volume of interest. The
white bins represent the raw data distribution and the gray bins the distribution after a
“shape filter” applied on the same segmented ROIs.
5.5 Highest resolution at SLS
The last experimental section of this chapter is dedicated to the visual-
ization of single marked cells at high resolution. The in vitro measurements
have been performed at the TOMCAT beamline at SLS. TOMCAT is a BL
dedicated for x-ray CT that provide state of the art on SR imaging exper-
iments at high spatial resolution. The latter is due to a superbend source
in combination with a multilayer monochromator that provide high photon
flux [76]. The experiment has been conducted at the highest resolution pos-
sible at TOMCAT using an optical lens system that magnifies 20 times the
optical light emitted by the scintillator. At this magnification the effective
pixel size can be quoted nominally as 370 nm and the FOV is 0.75 × 0.75
mm2. The imaging parameters and the SLS and TOMCAT characteristics
are summarized in Table 5.4.
A representative result of the measurements is shown in Figure 5.10,
where a single slice (a) shows three single C6 cells each one as an accumula-
tion of smaller absorbing spots that can be identified as cluster of gold NPs
embedded in the cytoplast of the cells. In the 3D rendering of Figure 5.10(b)
a void round part in the center of the cell is visible which can be identified
with the cell nucleus. This supports also the findings from TEM-SEM that
the NPs are not able to enter the nucleus. Moreover, the CT results confirm
what has been found analyzing the SEM measurements presented in Chapter
4 and in particular in Figure 4.4, 4.5(a) and 4.8: the gold NPs are organized
in clusters inside the cells. The more interesting fact is the possibility to
study the NPs distribution in 3D inside the cells while keeping them in their
natural state.
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Table 5.4: Summary of the SLS, TOMCAT beamlines parameters and the imaging
characteristics.
SLS & TOMCAT characteristics
Electron energy 2.4 GeV
Ring current 400 mA
Radius 46 m
Source 2.9 T Superbend
Critic Energy 11.1 keV
Energy Range 8 ÷ 45 keV
Beam size 40 mm × (7 ÷ 4) mm @ 20 m
CT parameters
Energy 12 keV
Magnification factor 20
Pixel depth 12 bit
Effective pixel size 370 nm
Exposure time 100 ms
No. projections 1501
Total time 2 min 30 s
FOV 0.75 × 0.75 mm2
20 μm
(a) (b)
Figure 5.10: Reconstructed CT slice obtained at TOMCAT beamline using the 20x
magnified optic. (a) In the slice the white spots are single C6 cells within smaller spots
that are the cluster of NPs inside the cells. (b) In the 3D rendering the NPs clusters are
better visible around the void nucleus. The images are obtained using the software OsiriX.
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5.6 Discussion
In this chapter the experimental validation of cell tracking using gold
NPs as cellular marker and x-ray CT has been described. For the first time
an x-ray based imaging investigation has been exploited on in vitro samples.
Samples consisting of gold marked C6 cells embedded in gel agarose have
been measured under different experimental conditions. A first measure-
ment at the CLS confirmed the suitability of gold NPs as cellular markers in
combination with x-ray CT. The spatial resolution of about 20 µm permit-
ted to visualize with sufficient signal cluster of C6 cells, however, single cells
were barely visible. In a second experiment a “bragg magnifier” has been
used at SYRMEP beamline to increase the spatial resolution of the imaging
system. In this way the effective pixel size became 1.4 µm and the PSF
equal to 4.7 µm. With this set up single cells are well visible. A method
to measure the cellular volume distribution has been developed and applied
to a VOI. The lower threshold for the image segmentation has been found a
crucial parameter that change strongly the output volume. Obviously lower
thresholds tends to add noise in the cellular volume. For this reason it is
important to reduce the background noise. The resulted volume distribution
is large (indicator of a variation of volumes) and centered in ∼ 500 µm3. The
method has been applied on the same sample with data sets acquired us-
ing the conventional µ-focus tube available at TOMOLAB facility. Here the
magnification can be tuned changing the relative distances between source,
object and detector. Using a magnification factor of 6 the effective pixel
became 4.17 µm and the PSF ∼ 16 µm. In this configuration the visualiza-
tion of the marked cells has been possible using a polychromatic beam. The
larger PSF in combination with the polychromatic beam impede the single
cell recognition. The volume distribution analysis yielded similar results as
the in case of synchrotron radiation if a suitable filter is applied. To avoid
the high background noise contribution a shape filter on the segmented ROIs
has been necessary. The last experiments described in this Chapter has been
carried out at TOMCAT beamline at SLS that provided very high spatial
resolution achieved with a pixel size of 370 nm and a PSF of ∼ 1 µm. The
system permits to visualize clusters of NPs inside the C6 cells as seen in the
SEM measurement but in 3D in an effective sub-cellular resolution. Summa-
rizing, in this chapter it has been shown that there is no physical limit for in
vitro cell tracking combining gold NPs and x-ray imaging. The conventional
µ-focus x-ray source exhibited almost single cell sensitivity. Moreover it
turned out that the spatial resolution, which is achievable using synchrotron
radiation is substantial higher than required to render a single cell.
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Chapter 6
Ex vivo x-ray cell tracking
experiments
In the Chapter 5 we have demonstrated the visibility of gold loaded cells
on in vitro samples. This Chapter is dedicated to investigate what happens
to the marked cells once they are injected in a living being and to disclose if
they remain visible. Several ex vivo experiments have carried out as proofs-
of-principle of this technique using different cells line and host animals.
6.1 C6 cells in rats
The possibility to track the position of few marked tumor cells could
help to understand the dynamics of tumor grow and metastasis spread [84–
88]. Therefore the first studies on x-ray cell tracking have been carried out
on tumor cells. Here C6 cells that had been also used in the experiments
described in the previous Chapter 5 have been injected into the rat brains
or into the spinal cord to visualize and localize the tumor ex vivo.
6.1.1 Preparation
The C6 cells (which mimics the human glioblastoma multiforme (GBM)
in a rat models) have been loaded with gold NPs as described in Section
4.1. Then a different amount of marked C6 cells has been injected directly
into the rat brain or into the spinal cord. Adult male Wistar rats were used
for these experiments. The implantation procedure was performed under
general inhalation anesthesia. Induction of anesthesia was achieved with 5
% Halothane in 2 l/min of oxygen, and maintenance of anesthesia with 1.5 - 2
% Halothane in 1.5 l/min of oxygen. A dose of 0.05 mg/kg Buprenorphin s.c.
was given as pre-medication. The back of the animal was shaved, disinfected
with chlorhexidine and 70 % alcohol in case of spinal cord injection. The
head of the animal was fixed between the ear bars of a stereotactic frame and
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the animal’s body was straightened and supported in a tissue nest on the
frame’s ground plate. A straight vertical midline incision was then made over
the spinal processes of the mid-thoracic cord and a spreader was introduced
to keep the wound edges apart. A burr hole of about 0.6 mm diameter was
placed in the right lamina of the 7th vertebra. Following these preparatory
steps a number running from 50 000 to 1 000 000 cells were drawn up into
a Hamilton syringe in a volume of 10 µl and a 27 G needle was fixed to
the Hamilton syringe for injection of the cell suspension into the rat brain
or into the spinal cord. The Hamilton syringe with the cell suspension was
mounted in the pump driver of a microinjector pump (KDS 310, Geneq)
that was fixed to the vertical arm of the stereotactic frame. The Hamilton
syringe was lowered carefully through the burr hole so that the tip of the
needle just touched the dura mater. Using the vertical arm of the stereotactic
frame, the tip of the needle was now introduced 2.5 mm below the cortical
surface. The cell suspension was then slowly injected into the spinal cord
over a period of 4 minutes, with the aim to keep the mechanical damage from
the implantation procedure to a minimum. After the end of the injection,
the needle was carefully withdrawn, the burr hole sealed with bone wax
and the skin was sutured. The animal was allowed to recover and cared
for whilst the tumor developed over a period running from 3 to 16 days.
Both animals (tumor-bearing and control animals) were then sacrificed by
pericardiac perfusion with normal saline and 10 % Formalin (about 1 ml of
each per 1 g rat). The spines of the animals and the heads were dissected
and used for imaging. The same procedure has been run for healthy samples
where the unmarked C6 cells has been injected.
All the experimental part presented in this Section have been conducted
at the University of Saskatchewan and they conformed to the guidelines of
the Canadian Council for Animal Care. Table 6.1 summarizes the presented
samples preparation details.
Table 6.1: Summary of the samples presented in this section for the C6 cells tracking in
rats.
Name Marker No. cells Part Days
Rat3 Yes 6 × 105 Head 14
Rat10 No 6 × 105 Head 14
EL09-11 Yes 1 × 105 Head 16
Sample 706 Yes 5 × 104 Spinal cord 14
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6.1.2 Results
Rat3 and Rat10
The two animals (Rat3 and Rat10) injected with the same amount of
C6 cells (600 000) and have been sacrificed 14 days after the injection. The
rats heads were placed into syringe holders (with an external diameter of ∼
23 mm) filled with 10 % PFA to preserve them and keep them still during
the acquisition. The only difference was that Rat3 received marked cell and
Rat10 received naïve cells. Images of the animals have been acquired at
the SYRMEP beamline using the 14PhSci detector (described in Section
3.2) coupled with the 20 µm thick scintillator at binning 1 (PSF ∼ 34 µm)
collecting 720 projections over 180◦. The distance between the sample and
the detector was around 80 cm yielding some free propagation phase contrast
in the edge enhancement regime (as described in Section 2.3). The total
acquisition time was approximately 1 hour. Figure 6.1 shows virtual 3D
renderings of the skulls of both animals for a qualitative comparison. In both
samples the injection hole is visible but only in Rat3 a big and round tumor
is prominent (∼ 4-5 mm in diameter) as shows in Figure 6.1(a). The tumor
is detectable because of the higher linear absorption coefficient stemming
from the gold NPs. Due to the absence of the marker naïve C6 cells are
indistinguishable from the background as visible in Figure 6.1(b). Figure
6.2 shows a detailed 3D rendering of the Rat3 tumor and its H&E stained
that was performed to verify the presence of tumor cells and subsequently
to verify the findings of x-ray CT. The result confirms the presence of C6
cells on the boundary of a cyst. The distribution of the C6 cells revealed by
x-ray CT matches that found by histology.
5 mm
burr hole
tumor
(a)
5 mm
burr hole
(b)
Figure 6.1: 3D renderings of the skull of two animals injected with gold loaded C6 cells
(Rat3 a) and injected with unmarked C6 cells (Rat 10 b). These images and the following
ones are obtained using the software OsiriX.
77
- Ex vivo x-ray cell tracking experiments -
2 mm
(a)
4 mm
(b)
Figure 6.2: X-ray 3D rendering of the tumor detected in the sample Rat3 (a) compared
with its histology (b).
EL09-11
Another sample (EL09-11) was injected with 100 000 gold loaded C6 cells
into the brain and has been sacrificed after an incubation time of 16 days.
As before the head has been preserved in a 10 % PFA solution and placed in
a syringe holder. CT scans were carried out at the SYRMEP beamline and
at the TOMOLAB facility. For the former the x-ray energy was set to 20
keV and the 14PhSci detector was employed coupled with the 20 µm thick
scintillator. At the latter the voltage of the x-ray tube was set to 50 kV wand
imaging was performed with a current of 133 µA. The low energy part of the
spectrum was filtered using a 0.5 mm thick aluminum. At TOMOLAB two
CT methods have been use in order to achieve better visibility. Firstly the
sample has been scanned at full FOV with a pixel size of 12.5 µm and a FOV
of ∼ 25 × 16 mm2. Secondly a scan in LT mode zooming into the tumor
region with a pixel size of 5 µm and a FOV of ∼ 10 × 7 mm2 was carried
out. It is shown the resulting 3D renderings of sample EL09-11 obtained at
the synchrotron radiation facility SYRMEP and at the µ-focus x-ray tube
station in Figure 6.3(a) and Figure 6.3(b) respectively. The images show
an accumulation of bone debris close to the injection hole and two regions
with a somewhat lower contrast than the bone debris. One is located close
to the burr hole and the other approximately 6 mm far from it towards the
front of the skull. Both the lower absorption as well as the position of the
regions suggest that the signal stems from an accumulation of gold NPs and
thus is due to the presence of C6 cells. The fact that the tumor developed
into two well-separated masses allows some interpretations: a) A primary
tumor could have developed near the injection hole and a secondary tumor
could have grown independently far away from the primary. b) A large
tumor developed with an asymmetric distribution of the cellular marker, not
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Figure 6.3: Sample EL09-11: 3D renderings obtained using synchrotron radiation at
SYRMEP beamline (a) and using a micro-focus x-ray tube at the TOMOLAB facility (b).
unusual for GBM or c) prior to cell homing the injected cells moved actively
to the two distinguishable zones. A zoom of the so-called secondary tumor is
shown in Figure 6.4 for a comparison of the two different acquisition systems
(BL and BT). Moreover, Figure 6.5 shows the tumor detail obtained using
the LT at TOMOLAB. In general the reconstructions from the BT data are
more noisy than the one obtained from the BL data sets and therefore it
is more difficult to segment the ROIs. Utilizing the “Region_Grow” IDL1
function, segmentation was applied to the data cubes obtained in the three
different modalities. Using the same detail as seen in all three cases (and
different thresholds) the following volumes for the secondary tumor have
been found: (8.1 ± 1.5) × 107 µm3 at BL; (2.0 ± 0.3) × 107 µm3 at BT
and (3.1 ± 1.2) × 107 µm3 at BT in LT. These results confirm a better
sensibility at BL that permits a finer recognition of cells. Even though the
effective pixel size of the BT in LT mode is smaller the higher background
noise and subsequently the choice of the segmentation threshold introduces
additional uncertainties and therefore larger errors the number of retrieved
cells. For example, the order of magnitude of the BL segmented VOI is ≈
160 000 marked cells, considering the C6 volume of 500 µm3 as measured in
Chapter 5.
Sample 706
Since GBMs can develop in the entire central nervous system some an-
imals were injected with marked C6 cells into the spinal cord. Rat 706
received 50 000 cells and was sacrificed after an incubation time of 14 days.
The vertebral column was removed and has been preserved into a Falcon
1 Interactive Data Language software.
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1 mm
(a)
1 mm
(b)
Figure 6.4: 3D renderings of the secondary tumor in higher magnification obtained from
the data acquires at (a) the SYRMEP beam line and (b) using a µ-focus x-ray tube
1 mm
Figure 6.5: 3D renderings of the secondary tumor in higher magnification using a micro-
focus x-ray tube at the TOMOLAB facility in LT.
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tube filled with 10 % PFA. The vertebral column has been scanned in this
container at SYRMEP beamline using the 14PhSci detector equipped with
the 20 µm thick scintillator at 24 keV. The number of projections was 900
over 180◦. In Figure 6.6 the 3D rendering of the reconstructed data is shown.
An accumulation of C6 cells is visible in the center of the vertebral column.
Apparently the tumor grew along the tubular bundles of nervous tissue in
longitudinal direction as is depicted in Figure 6.6(b). The detail segmented
volume is 0.10 ± 0.06 mm3 that corresponds to ≈ 200 000 C6 cells.
5 mm
(a)
5 mm
(b)
Figure 6.6: Vertebral column of sample 706: 3D renderings obtained using synchrotron
radiation at SYRMEP beamline in axial (a) and coronal (b) views. The images show an
accumulation of C6 cells in the center of the vertebra.
81
- Ex vivo x-ray cell tracking experiments -
6.2 F98 cells in mice
Following the results presented in the previous Section the same kind of
procedure has been applied to study the behavior of another cell line (F98
cells) in a different animal model on mice. As C6 cells the F98 mimics in
rodents the human brain GBM. This time only one representative sample
will be analyzed with two x-ray CT techniques. This experiment has been
conducted in preparation of the one presented in Chapter 8.
6.2.1 Preparation
The cell loading, cell harvest and cell implantation procedure here are
the same as the one for the C6 cells on rats however, instead of Wistar rats
athymic mice (nu/nu) have been used. Either 100 000 or 200 000 marked F98
cells have been implanted in the brains of mice. As before the head of the
sample has been kept for the imaging acquisition and preserved in a PFA
solution.
6.2.2 Results
X-ray CT
The x-ray CT data was acquired at the TOMCAT beamline at SLS (de-
scribed in 5.4) using a photon energy of 22 keV and 2 501 projections over
180◦. X-rays are converted to visible photons using a 20 µm LAG scintillator
and projected utilizing 1.25× objective lenses system onto a fast scan CCD.
The system provides an effective pixel size of 5.9 µm. Figure 6.7 shows a 3D
rendering of the acquired data cube. An accumulation of the cellular marker
is clearly noticeable close to the injection hole. A careful analysis on the slice
data using MIP over 32 slices (that translates into a ∼ 190 µm thick head
slice) reveals a weak signal of a borderline of a larger detail (around 2.5 × 4
mm2) that could be interpreted as the tumor boundary as seen also in the
C6 cells experiments. Moreover, a higher marker accumulation in the center
(Figure 6.8) of the larger structure is evident. In order to render the real
tumor boundaries a GI setup (based on the principles described in Section
2.3.2) available at TOMCAT beamline was employed.
Grating interferometer CT
The GI setup permits to separate phase and absorption effects on x-rays
induced by an object. In our experimental case the mouse head presents
an high absorption mainly due to the skull that reduces the fringe intensity.
Therefore the imaging procedure has been conducted accordingly with the
experiment presented in Ref [89]. As shown in Figure 6.9(a) the brain has
been removed obtaining a more suitable configuration for increasing the final
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5 mm
tumor
burr hole
Figure 6.7: Head of sample F10-1-3 in 3D. The injection hole is visible as well as an
accumulation marked F98 cells, indicating the tumor
3 mm
Figure 6.8: An axial MIP over 32 slices of the sample F10-1-3 head. The combination
of MIP and an appropriate windowing reveals a weak absorbing border around the high
absorption accumulation.
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image quality. A second experimental procedure used was to place the brain
in a saline aquarium to avoid strong phase variation in the interfaces that
can cause large perturbation of the fringes as shown in Figure 6.9(b). The
(a) (b)
Figure 6.9: Photo of the removing procedure of the brain of sample F10-1-3 (a) and the
removed brain dived into the aquarium (b) for the GI scan.
scan has been conducted in CT mode collecting 2 501 projections at 26 keV.
The absorbing grating has been scanned over 7 step and the total brain
acquisition requested 3 CT stacks of 3.1 mm height. Figure 6.10 shows a
Table 6.2: GI experiment parameters.
Parameter Value
Energy 26 keV
No. projections 2 501
Objective 1.25 ×
effective pixel 1.4 µm
FOV 12.1 × 3.1 mm2
Exposure time 0.2 s
Total scan time 3 h 15 min
Grid step 7
CT stacks 3
slice of the brain phase reconstructed. The technique permits to visualize
the brain tumor without the need of contrast agent. The quality of the phase
contrast achieved can be compared with the MRI contrast. A comparison
of the shapes between the Figure 6.8 and the Figure 6.10 confirms that the
border detected using absorption x-ray CT is the tumor-brain interface.
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3 mm
Figure 6.10: Reconstructed slice of the Phase of sample F10-1-3 brain.
6.3 hMSC cells in mice
Up to now only malignant marked cell lines have been injected for ex
vivo experiments. Moreover, these labeled tumor cells have to be grafted
in specific positions of animals. In the following section the capability to
localize and to track non-malignant stem cells with x-rays is investigated on
mice. The experiment has been inspired by Nakamizo et al. article [90].
It is demonstrated that human mesenchymal stem cells injected into the
carotid artery of nude mice bearing brain tumors generated from human
U87 glioblastoma cells migrate towards and integrate into the malignant
gliomas. In other words such a system could provide a mechanism to direct
selectively markers towards naïve tumor sites.
6.3.1 Preparation
Generation of brain tumors
U87 glioma cells were grown to near-confluence, trypsinized and har-
vested. They were suspended in 0.03 mM PBS at a concentration of 107
cells/0.5 ml and kept on ice until implantation. Male athymic mice (nu/nu)
were anesthetized with an intraperitoneal injection of a mixture containing
1 mg Ketamine and 0.1 mg Xylazine/10 g mouse. Once asleep, the head
of the animal was wiped with chlorehexidine and 70 % alcohol. A straight
midline incision of the scalp was made and a burr hole was set about 2 mm
to the right of the sagittal suture and 2 mm behind the coronal suture. The
animal was then secured between the ear bars of a small animal stereotactic
frame (Model 963 Ultra Precise, David Kopf Instruments, Tujunga, U.S.A.).
The tip of a 27 G needle mounted on a Hamilton syringe filled with U87
cells suspended in 0.03 mM PBS was carefully lowered into the burr hole
and advanced 2 mm below the cortical surface. 100 000 U87 glioma cells
85
- Ex vivo x-ray cell tracking experiments -
suspended in 5 µl PBS were injected into the anterior aspect of the right
cerebral hemisphere over a period of 4 minutes, using an automated injector
pump. The needle was left in place for 2 minutes after the end of the in-
jection period and then carefully withdrawn. The skin was sutured and the
animals were allowed to recover.
Injection of hMSC
The marrow bone derived hMSC have been loaded with gold NPs as
described in Section 4.1. The cells were injected on day 13 after U87 glioma
cell injection, 24 or 72 hours before the animals were sacrificed. Among the
animals that received an injection of marked hMSC, one group received an
injection of 1 000 000 hMSC directly into the brain (11 mice; 4 sacrificed at
24 h and 7 after 72 h) and the other group received the same number of cells
injected into the right common carotid artery (11 mice; 6 sacrificed at 24 h
and 5 after 72 h). Animals were anesthetized with the mixture of Ketamine
and Xylazine as described above. For direct injection of the hMSC into the
brain tumor, 1 000 000 cells suspended in 10 µl of a-MEM plus 10 % FBS were
injected into the tumor at a rate of 1.5 µl/min, using the burr hole created
previously for the tumor cell injection. The technical set-up was identical to
that described for the injection of U87 cells except that a 30 G needle was
used this time. For injection into the right carotid artery, the animal was
placed on its back on a sterile draped styrofoam board. Fore and hind limbs
were fixed to the board and the head was gently rotated towards the left.
A vertical midline incision was made, the right common carotid artery was
exposed and two ligatures were loosely placed around the artery. 1 000 000
hMSC suspended in 200 µl of a-MEM plus 10 % FBS were slowly injected
into the common carotid artery through a 30 G needle directed distally. The
needle was left in place for about 30 s after the end of the injection and then
withdrawn, followed by a swift tightening of the two ligatures to prevent
hemorrhage or back flow of the injected cells and skin sutures.
All animals were sacrificed 14 days after glioma cell implantation by
an isoflurane overdose and decapitation. The heads were stored in 10 %
phosphate-buffered formalin for about two weeks before imaging. For the
imaging procedure, the mouse heads were snugly mounted into test tubes
filled with 10 % PFA.
6.3.2 CT acquisition
The CT acquisition has been conducted at SYRMEP BL at 24 keV using
both the 14PhSci at binning 1 (pixel size 14 µm - PSF ∼ 34 µm) and the
9PhSci detector at binning 3 (pixel size 13.5 µm - PSF ∼ 26 µm). The latter
has a smaller horizontal FOV (17.5 mm instead of 28.7 mm) which does not
accommodate the entire sample size. Therefore the CT has been acquired
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in a “360◦” mode, instead of the “180◦” commonly used rotation at the BL.
This permits a CT acquisition of samples with a size larger than the detector
FOV but smaller than twice. The procedure consists on placing the object
center of rotation in one extreme of the detector FOV illuminating a little bit
more than half sample. During the rotation over 360◦ a complete set of pro-
jections (equivalent of the common acquisition mode) is acquired for the CT
reconstruction. The only difference is a re arrangement of the sinograms that
can be performed using the STP software. In this experiment, the number
of projections has been 900 and 1 800 using a scan angle over 180◦ and 360◦
CT respectively. The sample-detector distance was around 40 cm to achieve
some phase contrast in the edge enhancement regime. Table 6.3 summarizes
the characteristics of the samples shown in details in the following.
Table 6.3: Summary of the samples presented in this section for the hMSC cells tracking
in mice.
Name Injection place Hours CT Mode
EL41-2 Carotid artery 24 360◦
EL31-1 Carotid artery 24 180◦
EL21-1 Brain 24 180◦
EL23-3 Brain 72 360◦
6.3.3 Results and discussion
In the 3D reconstructed data all three control animals exhibit some bone
debris close to the burr hole that feature a signal level similar to the marked
cell but they are different in shape. This is important for being able to
distinguish bone debris from the marked cells. Several mice injected through
the carotid artery showed a strong accumulation of marked cells close to
the injection point (8/11 mice), which indicates some problems during the
injection of the marker into the circulatory system (for instance the EL21-1
animal, which is shown in detail in the following). The other animals showed:
a large and almost spherical accumulation close to the burr hole in the case
of EL31-1 (which is shown in detail in the following) and the rest exhibited
only bone debris. The group of mice, in which the labeled hMSCs had been
directly injected into the brain, exhibited significant higher signals than the
previous group. In the day 1 group 2/4 mice showed a large amount of
marked cells distributed throughout the entire brain. As a representative
example the EL21-1 animal is shown in the following sections. Of the 3 days
group 3/7 exhibited similar findings. In the other mice, however, no labeled
cells or merely bone debris close to the burr hole have been detected. This
could be indicate that the major part of the cells migrated to other anatomic
locations which are out of the scanned FOV.
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EL41-2
The mouse EL41-2 had been injected with gold loaded hMSC through
the carotid artery and was sacrificed 24 hours after this injection. As shown
in the 3D rendering in Figure 6.11 and contrary to our expectations no
cells migrate towards and integrate into the malignant gliomas. Instead a
substantial accumulation of marked hMSCs is visible close to the injection
position (marked in blue). The measured volume can be quoted with 0.61
± 0.04 mm3, which translate into ≈ 1 200 000 cells assuming a cell diameter
of ∼ 10 µm. Although the primary goal to migrate the hMSCs towards the
tumor site was not reached in this case it nevertheless proofs the capability of
the x-ray method to locate and subsequently track injected cells in a different
anatomic position.
5 mm
Figure 6.11: Surface rendering of sample EL41-2 injected through the carotid artery and
sacrificed 1 day after. An accumulation of the injected marked cells has been detected
close the injection point (in blue).
EL21-1
The mouse EL21-1 had been injected with gold loaded hMSC directly
into the brain through the same burr hole that was used earlier to graft the
unlabeled U87 cells. The animal was sacrificed 24 hours after the adminis-
tration of hMSCs. Figure 6.12(a) shows the resulting 3D surface rendering in
which the hMCSs are segmented in blue. A very large number of details are
visible in the brain on both cerebral hemispheres. The 3D positions of the
clusters seem to be propagated and accumulated starting from the corpus
callosum, along the cingulum up to the external capsule as it is visible in
Figure 6.12. The image in Figure 6.12(b), taken from a mouse brain atlas2
confirms the anatomic position of the accumulated hMSC shown in Figures
2 Web size: http://www.mbl.org/atlas170/
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6.12(c) and 6.12(c) where the x-ray CT results is shown in MIP images over
14 slices that corresponds to ∼ 200 µm thick. The details are almost round
with a diameter ranging from 30 (around the detectable limit) to 270 µm
which translates into ≈ 30 ÷ 21 000 cells.
5 mm
(a)
cc
cg
ec
(b)
(c) (d)
Figure 6.12: Surface rendering of sample EL21-1 injected directly in the brain and
sacrificed 1 day later with all the accumulation points in blue (a). Reference image from
the mouse brain atlas (b) with the corpus callosum (cc), the cingulum (cg) and the external
capsule (ec) underlined. The two MIP images (c-d) of sample EL21-1 shows the marked
hMSC accumulation in cc, cg and ec.
EL23-3
The mouse EL23-3 had been prepared as the previous one but the animal
was sacrificed 72 hours after the injection. Figure 6.13 shows a 3D surface
rendering of the result obtained with the cells detected segmented in blue.
In contrast to the previous sample, here a small localized distribution of
labeled hMSC is along the injection channel and an accumulation close to
its terminal point is prominent. The position of the latter suggest that the
hMSC could be integrated into the naïve tumor which has been injected
around this position. Measuring the volume of the main accumulation it
results in 0.015 ± 0.003 mm3 (≈ 30 000 cells) which is about 3 % of the total
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injected cells. This could be an indication that the major part of the cells
migrated to other anatomic locations which are out of the scanned FOV.
5 mm
Figure 6.13: Surface rendering of sample EL23-3 injected directly in the brain and
sacrificed 3 days after. An accumulation of the injected marked stem cells has been
detected near the burr hole (in blue).
EL31-1
The mouse EL31-1 has been injected with gold loaded hMSC through the
carotid artery and sacrificed 24 hours after the injection. Figure 6.14 shows a
3D surface rendering revealing again a larger accumulation of labeled hMCSs
in the vicinity of the burr hole. The accumulation has a volume of 0.216 ±
0.013 mm3 which translates into ≈ 400 000 cells.
To verify if the marked hMSCs injected through the carotid artery appar-
ently migrated towards and integrated into the naïve U87 tumor, a second
and complementary imaging method (MRI) has been applied. The animal
was scanned after x-ray CT utilizing a small animal MRI scanner (Bruker
7 T). The sequence was a T2 weighted over a FOV of 21 × 21 × 21 mm3.
The plane resolution was 82 × 82 µm2 and the slice thickness of 164 µm.
The acquisition took a total of 14 h. The MRI reveals the presence of the
unmarked injected U87 tumor that has a diameter between 1.5 ÷ 1.9 mm
in a position 1 ÷ 1.5 mm far from the detected hMSCs as visible in Figure
6.15(a). This means that in this sample the hMSC have not migrated into
the tumor as aspected. Figure 6.15(b) shows the injection channel from the
hole to the tumor that is invisible with x-ray. The channel is characterize
by a black signal that can be stale blood accumulated after the injection
trauma. Analyzing carefully the CT slices in MIP mode in Figure 6.15(c)
and Figure 6.15(d) four higher attenuation ROIs are present in the injec-
tion channel zone. More likely the hMSC penetrate the brain through the
injection hole and have been stopped by the stale blood.
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5 mm
Figure 6.14: Surface rendering of sample EL31-1 injected through the carotid artery
and sacrificed 1 day after. An accumulation of the injected marked stem cells has been
detected near the burr hole (in blue).
5 mm
(a)
5 mm
(b)
5 mm
(c)
1mm
(d)
Figure 6.15: The MRI images (a-c) of sample EL31-1 injected with an unmarked tumor
and marked hMSC show the unmarked tumor (indicated in (a) by the arrows) and a black
blood channel caused by the injection (c). The x-ray CT images are MIP over 14 slices
show a big accumulation near the injection hole and four small spots along the injection
channel (b-d).
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6.4 OEC cells on rats
In the following Section the capability to localize and to track non-
malignant cells will be discussed which might be of great importance in
the field of regenerative medicine, which is based on the implantation of
pluripotent cells. The use of Olfactory Ensheathing Cells (OEC) to regener-
ate spinal cord injury has often been reported, see for example Refs [91, 92].
This section focuses on the capability of tracking OEC in a rat model of
spinal cord injuries. It is thought that OEC cell might be a support in
spinal cord regeneration studies.
6.4.1 Preparation
OEC were isolated from the outer nerve layers of olfactory bulbs of day 14
embryonal Wistar rats and grown to near-confluence. Cells were trypsinized
and harvested. Adult male Wistar rats were anesthetized with Isoflurane
(exactly like for the C6 implantation). The back was shaved and the skin was
disinfected with Chlorhexidine and 70 % alcohol. A vertical midline incision
was made over the spinous processes of the mid-thoracic spine. The muscles
were dissected off the laminae of Th 6 to Th 9 and the laminae were removed
(laminectomy). An aneurysm clip was closed for 5 s around the exposed
spinal cord at level Th 7. Thirty minutes later, 50 000 OEC suspended in 10
µl Hanks medium were injected into the spinal cord 2 segments caudal to the
site of injury, using an automated injector pump. After the injection, the
muscles and the skin were sutured and the animals were allowed to recover.
The animals were sacrificed 1 week after OEC implantation. The vertebral
column was removed and has been preserved into a Falcon tube filled with
10 % PFA used as sample holder for the CT acquisition. The scan has been
conducted at SYRMEP BL using the 14PhSci detector at binning 1 acquiring
a total of 900 projection over 180◦. The distance between the sample and the
detector was around 40 cm yielding some free propagation phase contrast in
the edge enhancement regime.
6.4.2 Results
As an example the 3D rendering of animal EL08-2 is shown in Figure
6.16. An accumulation of labeled OECs is clearly visible in the center of
the vertebra. The cell graft is recognizable as a “L” shaped detail with the
longer arm of about 750 µm and the shorter of about 250 µm. Apparently
the major part of the cell graft grew along the tubular bundles of nervous
tissue in longitudinal direction. Its section is close to be circular with a
diameter of about 70 µm. Measuring the volume it results in 0.012 ± 0.005
mm3 that translates into ≈ 25 000 cells. The animals treated with unmarked
OEC cells have not shown any accumulation.
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(b)
Figure 6.16: 3D renderings obtained of the spinal cord of sample EL08-2 using syn-
chrotron radiation at SYRMEP beamline in axial (a) and coronal (b) views. The images
shows a clearly visible accumulation of OECs in the center of the vertebra.
6.5 Discussion
In this Chapter several experiments of cell tracking conducted on ex vivo
samples have been presented. The goal of the experiments was to demon-
strate the possibility to locate and subsequently track marked cells using
x-ray CT not only in vitro (as presented in Chapter 5) but also in more
realistic experimental situations post mortem, which followed in vivo injec-
tion of the marked cells into the hosts. In a first experiment gold loaded
C6 cells have been injected in the heads or in the spinal cords of rats. The
post mortem CT scans accomplished at SYRMEP beamline and at TOMO-
LAB facility provided a detailed visualization of injected cells that had been
allowed to develop for a certain incubation time. Histology conducted on
some brains of the animals confirms that the accumulation visible in the CT
reconstruction indeed showed the tumors. Moreover the technique permits
to visualize also metastatic spread of tumors as seen on sample EL09-11.
On the presented Sample 706 that was injected on the spinal cord, the C6
cells has been accumulated in the preferential direction that follows the spinal
cord. A similar experiment has been accomplished on mice using gold loaded
F98 cells. The experiments have been carried out at the SLS, which apart
from conventional CT provides a GI setup that permitted a phase CT scan
of sectioned mouse brain. Deeper investigation on one sample revealed a
different growth behavior of F98 cells in mice with respect to C6 in rats. In
the former the tumor has a high cell concentration in the center of the tumor
and a low cell concentration on its boundary, a fact that has been confirmed
in the phase slices obtained with GI.
Experiments to explore the migration towards naïve tumors have been
conducted using gold loaded hMSCs in mice. Firstly an unmarked tumor
(100 000 U87 cells) was injected into the brain and the goal was to locate
1 000 000 marked hMSCs injected through the right carotid artery or directly
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on the brain 2 weeks after the tumor implantation. The mice have been sac-
rificed 1 or 3 days after the administration of marked hMSCs. Also in this
experiment the capacity of the x-ray based method to locate marked hMSC
has been confirmed. The biological interpretation of the findings, however, is
very complex: in some of the shown cases the hMSCs remained close to the
injection point around the carotid artery, in other cases a spread of hMSCs
clusters throughout the entire brain was observed. Using complementary
imaging modalities (MRI and x-ray CT) there have been some indications
that hMSCs injected into the carotid artery indeed trend to migrate to-
wards and integrate into the tumor. Eventually it was demonstrated that
the method could be applied in the field of regenerative medicine. It was
possible to locate marked OEC cell in the spinal cord of rats on rats. These
kinds of cells are promising candidates in the repair of spinal cord injuries.
The 3D renderings revealed OEC graft as a long and thin cell distribution
confirming the possibility to track OEC cells post mortem on rats.
The results show that x-ray cell tracking using gold NPs is feasible not
only in vitro (as shown in Chapter 5) but also post mortem in realistic animal
models of human deceases offering high resolution and penetration depth. In
the next chapters the possibility to transfer the technique from post mortem
towards in vivo experiments will be investigated.
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Chapter 7
X-ray cell tracking simulations
for in vivo experiments
The following part has been dedicated on the simulation of x-ray cell
tracking using our protocol starting from the cell loading to the image acqui-
sition, reconstruction and analysis. The importance of this work is manifold,
firstly it permits to deeply understand all the technical steps in terms of gold
concentration, imaging system resolution, x-ray dose issues and so on. This
is certainly only possible on the simulation level and impracticable using real
experiments (e.g. changing few code line is possible to control the cell distri-
bution and grow, the detector noise and resolution, the number of projection
used, the total radiation dose, etc.). Secondly, it is possible to evaluate the
limits of the imaging instrumentation to optimize the experiment around the
in-house technologies.
7.1 General software description
The x-ray cell tracking simulation code has been written in IDL software
language1 and is based on the code used by Rigon et al. for the simulation of
Diffraction Enhance Imaging processes [93, 94]. IDL is a scientific program-
ming language used across disciplines to create meaningful visualizations out
of complex numerical data and is commonly used at the SYRMEP beamline.
The software has been created in modules each one simulating a specific part
of the experiment. The first part creates the cell accumulation, loading them
with gold or other materials in the initial desired amount. It is possible to
simulate a series of mitosis processes miming for instance a tumor growth.
A second module creates the host model where the cells will be implanted.
The geometries have been retrieved from real CT data in order to be more
close to the experimental reality. Figure 7.1(a) shows the mouse model with
1 IDL version 8.0 http://www.ittvis.com
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the skull in black and the tissue in gray. The small simulated tumor is visible
in the lower and right part of the brain. The third module creates the CT
projections after merging together the simulated cells and the host geome-
tries in the desired position. The requested number of photons is generated
randomly and sent over the sample propagating them on rectilinear paths.
A statistical function generates pixel by pixel the absorption processes ac-
cordingly with the x-ray total attenuation coefficients assigned to the model
in “good geometry” configuration. The transmitted photons are collected in
a photon counting array that will be a line in the output sinogram. Then the
model is rotated for the other projections creating the full sinogram of the
simulated slice. In Figure 7.1(b) an example of the simulated sinogram is
depicted. It refers to the model in Figure 7.1(a). Each line in the sinogram
is a different angular view of the model. A forth module takes the sinograms
created for the slice reconstruction based on the filtered back projection al-
gorithm normally in STP software. In this last step it is possible to add
noise to the sinograms and a PSF simulating different detector behaviors.
The following scheme summarizes the parameter controlled by the simula-
tion software in the order of the simulation.
1. Cell model 2. Host model
- No. cells; - rat model;
- gold amount; - mouse model;
- gold dilution;
- tumor grow;
3. Projection creation 4. Slice reconstruction
- energy; - detector noise;
- No. photons; - resolution and PSF
- No. projections; - filters.
- Scan angle;
7.2 Simulated model
Among all the possible simulations that can be run, we have focus our
efforts on studying the in vivo feasibility of tumor cell tracking on mice using
the instrumentation available at the SYRMEP beamline. One important
issue that we want to investigate is the effect on the tumor visibility of CT
scans at low x-ray dose. At the same time, the visibility limits at very low
gold concentration inside the cells that occurs after several mitosis will be
studied. The simulated animal model is a mouse. We decided to scale down
on mice because of the limited FOV of the detector at SYRMEP that is
sufficient for ex vivo scans on rat heads fixed in a syringe container but not
for a living rat. The energy has been chosen to be high enough to traverse
the skull bone with low radiation dose deposition, but at same time to be
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(a) (b)
Figure 7.1: (a) The input model at the forth mitosis. The contrasts have been inverted
therefore darker shading represents a higher absorption. In this color scheme skull appears
in black color, the tissue in the gray, the tumor in darker gray and the air in white. (b)
The simulated 360 projection sinogram. Each rows is a projection at different rotational
angle.
comparable to the energy range available at SYRMEP beamline (8.5 ÷ 35
keV) and to the provided photon flux at the respective energy. Therefore
we fix the energy at 24 keV as in most of the post mortem experiments
at the BL presented in Chapter 6. The number of simulated projections
is 720, a quite high number in terms of computation time but it allows to
employ smaller subsets and to reconstruct the same slice using 360, 240, 180
projections reducing accordingly the radiation dose. Starting from a real
model acquired at 13.5 µm pixel size, the simulated detector pixel size has
been chosen as a multiple of that dimension. Finally the 54 µm pixel size
has been chosen to be close to the 56 µm of the 14PhSci detector pixel at
binning 4 and to the 50 µm of PICASSO. The PSF simulated has a FWHM
of 117 µm that is the PSF of 14PhSci CCD at binning 4 using the 40 µm
thick scintillator. Table 7.1 summarize the simulated parameters.
7.2.1 The tumor model
The tumor has been created as a sphere with an initial diameter of 250
µm containing the amount of gold measured in Section 4.1 on real cells (∼
26 500 gold nanoparticles per cell). On each mitosis the volume doubles
keeping the same total amount of gold. Consequently the gold density and
the tumor visibility bisects. Table 7.2 reports the simulated number of NPs
per cell in function of the cell mitosis and associated absorption coefficient
of the cells. It is clear that after several mitosis the contrast agent becomes
significantly diluted.
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Table 7.1: The parameters used for the low dose tumor tracking simulation.
Parameter Value
Animal Model Mouse
Photons energy 24 keV
No. Projections 720
Initial tumor diameter 250 µm
Cell mitosis 0 ÷ 7
Detector pixel size 54 µm
Detector type CCD
Detector PSF 117 µm
Table 7.2: The mean number of gold NPs per cell and the related linear absorption
coefficient of the labeled cells during the mitosis.
Marked cells Brain
Mitosis No. 0 1 2 3 4 5 6 7
No. NPs/cell 26500 13250 6625 3313 1656 828 414 207 X
µ [cm−1] 2.376 1.472 1.020 0.794 0.681 0.625 0.596 0.582 0.568
7.3 Reconstructed images analysis
An important issue of our cell tracking technique is the possibility to track
the position of cell clusters over a long-term period. However, the dilution
of the amount of gold NP will reduce the detectability of the gold loaded
cells with each mitosis (see Table 7.2). In order to analyze the simulated
slices correctly the CT version of the following quantities, the contrast C
(Equation 2.17), the SNR (Equation 2.18), the dose (Equation 2.19) and
the FoM (Equation 2.20) presented in Chapter 2 have been measured on
the output simulated data. The dose formula (that is only an approximation
obtained for a simplified geometry) is useful to understand behavior of the
radiation dose. For example, the dose scales with the square of SNR, the
inverse square of the contrast detail and increases strongly with the inverse
fourth power with the detail size. This indicates that the more efficient way
for reducing the radiation dose is sacrificing the spatial resolution that means
increasing the pixel size as it will be shown in the following Sections.
7.3.1 Detail segmentation
In cell tracking the capability to detect cells correctly and to separate
them from the background is absolutely important. Moreover the associated
volume of the cell grafts needs to be determined with the highest possible
precision. For the latter a software segmentation has applied as on the in
vitro CT results in Chapter 5. In the following, the segmentation rules
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analysis used for this Chapter will be described. Firstly we have to take into
account that the PSF (by definition) spreads the signal in the detector plane
and consequently in the 3D reconstruction. In a tumor image (also with
perfectly defined borders as in the simulation run) the PSF creates higher
signal in the core and smears the signal of the detail into the background
and subsequently into the image noise. A reasonable threshold (th) is the
mean between the background (µ1) and the expected signal (µ2):
th =
µ1 − µ2
2
[7.1]
The Equation 7.1 must to be applied to calibrated data in which the voxel
values are scaled on the detail linear attenuation coefficient.
7.3.2 Calibration and error measurements
Such calibration has to be performed on each slice. For simulated data
a three-point line fit taking air, brain and bone as reference is sufficient
for proper calibration. Due to the smaller number of pixels involved and
the non homogeneous skull model (because derived from real data) the bone
calibration point features some uncertainty. Therefore details with the higher
µ can be affected by a systematic error. Such errors can be attenuated using
small adjustments of the threshold. In the following analysis, the success of
segmentation, and consequently the recognition of the tumor, is evaluated
against the known simulated input. In general a round segmentation with an
area similar to the simulated tumor has been considered a good segmentation.
The propagated contrast error considered is:
σCµ =
√
1
µ21
σ2µ2 +
µ2
µ41
σ2µ1 [7.2]
where σµ2 is the noise measured in the detail and σµ1 is the measured back-
ground noise close the detail evaluated as the standard deviation of the mean
values of different background areas. The SNR error is:
σSNR =
√
1
σ2µ1
σ2µ2 +
1
σ2µ1
σ2µ1 +
(µ1 − µ2)2
σ4µ1
σ2σµ1
[7.3]
where σσµ1 is the error of the background noise (σµ1), measured as the mean
of the standard deviation of the involved areas. The FoM error is simply:
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σFoM =
σSNR√
dose
[7.4]
because the dose is exactly known.
Measuring the segmented areas a systematic error has been found to a
non proper calibration at higher attenuation values. It has been estimated of
about 3% therefore the threshold has been adjusted respect to the nominal
value of Equation 7.1. As done in Chapter 5, to evaluate the segmented areas
errors a threshold scan in an interval equivalent to twice the background
noise was performed. This interval was subdivided into ten thresholds and
for each of them a tumor segmentation was performed. The final segmented
area value and its associated error is the mean and the standard deviation
of this ten areas respectively.
7.4 Results
In order to compare the visibility and the quality of the reconstructions
at different entrance doses the simulations have run at different number of
photons per projection as shown in Table 7.3. The number of photons was
between 1.25× 105 ÷ 8× 107 ph/proj, that corresponds to a total entrance
dose from 40 mGy to 2.56 Gy using 720 projections. The last entrance dose
is comparable to the one used with post mortem samples. In the following
the attention has been focused on three simulations, a low dose, a high dose
and one featuring an entrance dose of 160 mGy (using 5× 105 ph/proj) that
is the approximate dose that is expected to be delivered on a CT in vivo
measurement at the SYRMEP beamline.
Table 7.3: Total entrance doses on the simulation run.
Simulations run
No. photons (×105) 1.25 2.5 5 10 20 40 80
Entrance dose [Gy] 0.04 0.08 0.16 0.32 0.64 1.28 2.56
7.4.1 Segmentations
The Figures 7.2, 7.3 and 7.4 show the succeeded tumor segmentation
of the simulations respectively at 40 mGy, 160 mGy and 2.56 Gy. In each
image the simulated tumor model is shown on the left, the reconstructed
tumor is in the center and the segmentation is on the right. The different
mitosis simulation are labeled with a for the initial tumor, b with for the
tumor after the first mitosis and so on. All the images have been adjusted to
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the same contrast value to permit a visual comparison of the tumor visibility
that can be very low also on the tumor model on the left part of the image.
A successful segmentation preserves the simulated tumor geometry, tak-
ing in account the low-resolution pixelation of the reconstructed images with
respect to the model. At very low dose CT the segmentation works only for
the initial gold density and for the very first mitosis as in Figures 7.2(a) and
7.2(b) because of the low statistic that governs the background noise.
At higher radiation dose and subsequently at higher SNR (Figure 7.3)
also those tumors encompassing cells that underwent two mitosis are vis-
ible and measurable. The high dose simulation permits to measure also
low contrast tumors, up to the fifth mitosis as in Figure 7.4(f). The lower
background noise at higher doses permits a better segmentation and better
tumors visibility when compared for example to the central images in Figures
7.2, 7.3 and 7.4. Table 7.4 summarizes the SNR of the segmented tumor at
the three different doses studied.
(a)
(b)
Figure 7.2: Images of the modeled tumor (left), the reconstructed tumor (center) and
the segmented tumor (right) at mitosis zero (a) and after one mitosis (b). The simulations
considered a total entrance dose of 40 mGy over 720 projections.
Table 7.4: SNR on the segmented areas at different total entrance doses.
Entrance dose [Gy] Measured SNR
Mit 0 Mit 1 Mit 2 Mit 3 Mit 4 Mit 5
0.04 64 ± 18 37 ± 9 - - - -
0.16 110 ± 20 66 ± 17 29 ± 7 - - -
2.56 310 ± 70 170 ± 30 74 ± 16 54 ± 12 23 ± 6 12 ± 5
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(a)
(b) (c)
Figure 7.3: Images of the modeled tumor (left), the reconstructed tumor (center) and
the segmented tumor (right) at mitosis zero (a), after one (b) and two cell cycles (c) of a
simulation with a total entrance dose of 160 mGy over 720 projections.
(a)
(b) (c)
(d) (e)
(f)
Figure 7.4: Images of the modeled tumor (left), the reconstructed tumor (center) and
the segmented tumor (right) at mitosis from zero (a) to five (f) of a simulation with a
total entrance dose of 2.56 Gy over 720 projections.
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7.4.2 Contrast and SNR evaluation
The graph in Figure 7.5 shows the measured tumor areas on segmented
details in function of the simulated areas for the simulations at 40 mGy, 160
mGy and 2.56 Gy entrance dose. At high mitosis the tumor is visible only
on the 2.56 Gy simulation. There is a general good agreement between the
measured and the simulated areas. The ample error bars at larger area data
points is due to the substantial change on the segmentations caused by small
deviation on the threshold value.
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Figure 7.5: Measured segmented tumor areas on simulations performed at different
doses. The triangles, the squares and the circles refer to the 40 mGy, 160 mGy and the
2.56 Gy simulation respectively. The black line indicate the simulated area.
In Figure 7.6(a) the measured contrasts of the segmented details are
shown as function of the simulated contrasts. As before the analysis was
performed on simulations at 40 mGy, 160 mGy and 2.56 Gy entrance dose.
Within the error base there is a good agreement between the simulated
and the measured contrasts at least for small contrast values. For higher
contrast values the agreement remains still within the ample error bars but
a systematic trend towards smaller measured contrast values is obvious. This
fact is due to the calibration that is more precise on low µ details (around
µair and µbrain) with respect to those that are close to the linear absorption
coefficient of bone µbone thus as for tumors encompassing the initial gold
concentration.
In Figure 7.6(b) the measured SNR is shown as function of the measured
contrast for the high dose simulation only to include the lower contrast de-
tails. As expected from Equation 2.19 the linear fit on the data confirms the
linearity of SNR versus C at constant dose.
Figure 7.7(a) shows the behavior of the SNR as function of the dose
for the initial stage of the tumor. Different photon fluences and different
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Figure 7.6: (a) Measured segmented tumor contrasts on simulations at different doses.
The triangles, the squares and the circles refer to the 40 mGy, 160 mGy and the 2.56
Gy simulation respectively. The black line indicate the simulated contrast. (b) Measured
segmented tumor SNR over measured contrasts at fixed entrance dose (2.56 Gy).
numbers of projections (720, 360, 240, 180 and 90 projections) have been
used for the reconstructions. At points of equal entrance doses (e.g. 360
projections at 5×105 ph/proj and 720 projections at 2.5×105 ph/proj), the
weighted mean has been used with the weighted standard deviation2 [95].
As expected and according to Equation 2.19 the SNR follows a square-root
function. Therefore a square root fit according to the formula:
SNR = c1
√
dose [7.5]
2xbest = (Σiwixi)/Σiwi; σxbest = (Σ(1/σ
2
i ))
−1/2
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with c1 as free parameter was applied to the data. The choice of a single
parameter fit function is justified since there is no need of a baseline param-
eter. In other words at zero entrance dose the SNR vanishes. According to
Equation 7.4, c1 can be identified with the FoM . The resulted fit for the
mitosis zero is shown as black line. The χ2/ν = 0.58 (reduced χ2) justi-
fies these assumptions. Table 7.5 summarize the fit results shown in Figure
7.7(b) up to the fourth mitosis for a given entrance dose which is necessary
to obtain a SNR equal to 20.
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Figure 7.7: (a) Measured SNR of the segmented tumor versus entrance doses. Different
entrance doses have been obtained in varying the photon fluence and the number of pro-
jections used for the reconstruction within the fitting curve of Equation 7.5. (b) The same
fit repeated at different mitosis (Mit 0 ÷ Mit 4). The dotted line represents the SNR =
20 that is a reasonable SNR to visualize and segment the detail.
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Table 7.5: Table of the fits on simulated data for mitosis from 0 to 4. The last column
indicate the dose required for a SNR of 20 that assure a good segmentation. The reduced
χ2 is a measure for the quality of the fit.
Mitosis No. χ2/ν FoM Dose (SNR = 20)
[Gy−1/2] [mGy]
0 0.58 257 ± 10 6.06 ± 0.05
1 1.36 134 ± 5 22.3 ± 0.3
2 0.81 68 ± 3 86 ± 3
3 0.30 38 ± 3 277 ± 15
4 0.66 17.2 ± 1.9 1350 ± 160
7.5 Low dose CT at SYRMEP beamline
7.5.1 Detector choice
Taking into account these results in the following the characteristics of
the detectors available at SYRMEP beamline are analyzed with regard to
in vivo experiments. An ideal detector for in vivo imaging on small rodents
would encompass a FOV greater or equal to the mouse holder (∼ 26 mm),
a pixel size around 50 ÷ 60 µm and an efficiency close to 1 to permit a low
dose CT scan as demonstrated in the previous Sections. The PSF should be
equal to the pixel size in order to obtain the best resolution possible at the
dose delivered. The image readout and the minimum exposure time should
be as low as possible in order to have short scans that permits a minimal
anesthesia to the animal. The dynamic range should be as high as possible
to distinguish the very small change in absorption on the details. The noise
should be at least three times smaller than the associated Poisson noise
of the weakest signal. In Table 7.6 are compared the characteristics of the
SYRMEP detectors to the ideal one. Despite of very attractive characteristic
Table 7.6: Summary of the SYRMEP digital detector characteristics compared with an
ideal detector for low dose cell tracking.
Ideal detector 14PhSci 9PhSci Picasso
FOV [mm2] > 26 × 3 28.7 × 28.7 17.5 × 11.8 211.2 × 0.3
Pixel size [µm] 50 ÷ 60 56 36 50
PSF [µm] 50 ÷ 60 117 56 50
Readout [s] ≈ 0 1.2 0.4 0.001
Min. Exp. [ms] ≈ 0 700 50 10
DR [counts] ≈ ∞ 3568 4170 8 × 107
Efficiency [%] ≈ 100 ≈ 50 ≈ 14 ≈ 78
for the in vivo experiments such as 50 µm PSF, high efficiency, low noise
and infinite dynamic range the PICASSO detector is not really suited since
106
7.5 — Low dose CT at SYRMEP beamline —
it records only one slice at a time. Restricting the choice between the two
CCD available at SYRMEP beamline, the ideal pixel size, the FOV and the
higher efficiency make the 14PhSci detector the preferable choice even in
spite of the long readout time.
7.5.2 Low dose CT on an ex vivo sample
To validate the simulations and the detector choice for an in vivo ex-
periment, a low dose CT experiment has been carried out on an ex vivo
sample. The rat EL09-11 shown in Section 6.1 has been used because it
presents a low contrast detail at a well known position. The measurement
were accomplished using the 14PhSci CCD detector equipped with the 40 µm
scintillator. Three CT scans have been performed with different signal levels
(average gray values around 50 000, 30 000 and 10 000 on a 16 bit scale) with
a total entrance dose of 190, 110 and 36 mGy respectively. Figure 7.8 shows
a reconstructed slice of the sample inside its syringe container. The green
square indicates the detail used to evaluate the efficacy of the CT measure-
ment. The Figure 7.9 depicts a magnification of the detail obtained at the
1 cm
Figure 7.8: The slice analyzed for the low dose CT on the sample EL09-11. The green
square indicates the detail under exam.
different entrance dose of 190 mGy 110 mGy and 36 mGy in Figures 7.9(a),
7.9(b) and 7.9(a) respectively together with their segmentations, which had
been obtained using the “REGION_GROW” function of IDL. The images
show that the algorithm is able to segment correctly the detail in the 190
mGy CT. For the 110 mGy CT the associated image noise starts to compro-
mise the segmentation and in the 36 mGy CT the detail disappears because
of the background noise. Considering the efficiency of the detector, the ex-
periment confirms that a CT with an entrance dose between 70 ÷ 150 mGy
permits the visualization of a gold loaded cells cluster.
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(a) (b)
(c)
Figure 7.9: Images of the detail under exam in the reconstructed slice (left) and its
segmentation (right) at different entrance doses, 190 mGy (a), 110 mGy (b) and 36 mGy
(c).
7.6 Discussion
In this Chapter a study using a Monte Carlo simulation based on an IDL
code has been described which was designed to elucidate the limitations of
cell tracking using gold nanoparticles. The goal of the study was to evaluate
the physical feasibility of cell tracking at low x-ray doses. The software is
described in details as well as the tools used to evaluate the quality of the
output images. As known, the most efficient way to reduce the entrance dose
is to increase the pixel size, which subsequently results in the reduction of
the number of projections. From the simulations it turns out that a pixel
size of around 50 ÷ 60 µm is a good compromise to drastically reduce the
entrance dose with respect to the ex vivo experiments of Chapter 6 and to
have simultaneously a reasonable SNR images. Using the simulations the
minimum doses in order to obtain a sufficient SNR have been calculated in
function of the marker dilution. A minimum dose of 86 mGy is required to
correctly segment a tumor comprising cells that accomplished two mitosis,
or in other words cells that contain one quarter of the initial marker amount.
For higher dilution, the dose required becomes higher up to 1.35 Gy to vi-
sualize a tumor containing one sixteenth of the initial marker concentration.
These results have been verified experimentally on a known post mortem
sample at the SYRMEP beamline using the 14PhSci CCD detector. It was
demonstrated that an entrance dose of 190 mGy is sufficient to reveal the
weak signal of a gold loaded brain tumor and to segment it adequately. On
the basis of these findings the in vivo cell tracking experiments have been
designed at the SYRMEP beamline.
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Chapter 8
In vivo x-ray cell tracking
experiment
The possibility of locating and tracking F98 cells in an ex vivo mouse
model has been demonstrated in Section 6.2. The following Chapter de-
scribes subsequent in vivo experiments accomplished at SYRMEP beamline
on mice using this cell line. The goal of this experiment was to demonstrate
the feasibility of the technique in vivo in low dose modality and to elucidate
its limits. The experiment should be considered as a pilot study for in vivo
x-ray cell tracking experiments. With regard to longitudinal real time cell
tracking, which means to follow the disease or the effect of a cure over long
time on an individual animal, very low radiation doses have been applied.
According to national Italian and international legislation the in vivo
trials required thorough approval by the Local and National Ethics Com-
mittee since these were the first in vivo animal experiment carried out at
the SYRMEP beamline and in the field of x-ray cell tracking. Permissions
had been granted under the condition to sacrifice the animals following the
measurements.1
8.1 Experiment preparation
8.1.1 Animal holder
The animal holder has an essential role on the in vivo experiment, since
any movement of the animal can jeopardize the entire CT acquisition. More-
over it has to be designed such that it is compatible with the available instru-
mentation and at the same time does not affect the biological function of the
animal. In contrast to conventional x-ray CT systems in which the source
detector system rotates around a stationary animal the peculiar aspects of
1 Request Prot. No. 20100767/AF/00051; Sanitary permission Prot. No. 44846;
Ministry permission prot. No. 0018595-P-18/10/2010.
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SR is that the animal turns through a motionless source-detector system.
This constrains implies some difficulties for in vivo measurements using SR.
A special holder for the in vivo brain imaging experiments has been designed
accomplishing the following requirements:
stable the holder should be stable to avoid problems during measurements
or the sample fixation;
comfortable the animal comfort is a priority to avoid animal stress dur-
ing and after the measurements, the biological function should not be
hampered;
adaptable the holder should be adjustable to a certain extent, to accom-
modate animals that might differ in height and weight;
transparent the holder should not alter the x-ray beam, thus being
transparent for x-ray at the imaging areas;
centerable the holder should fit in the FOV of the detector and should
remained centered during the rotation;
accessible the animal must be fixed in a easy way to avoid waste of time
during the anesthesia and the animal must be visible and reachable for
any rescue procedures in case of emergency.
Taking in account the previous points, the final holder has been realized as
depicted in Figure 8.1. A solid aluminum base (part No. 10) and the main
hollow aluminum bar (No. 6) assure sufficient stiffness of the holder. A
plastic piston (No. 4) can be positioned in height and fixed with a screw
(No. 5) adjusting the holder to an individual rodent. The animal sits on a
cushion on the aluminum base hugging the piston (No. 4, 6) in a comfortable
way. The head is kept in the semi cylindrical thin Lucite extension (No. 1)
that absorbs an acceptable fraction of the x-rays. The animal and its head are
kept in place tying its incisor teeth with a thin thread up to the back of the
Lucite part (No. 1). The animal is free to breath and the breathing motion
affects the head stability insignificantly. Moving the hollow aluminum bar
horizontally along a guide (No. 7) it is possible to correct the center of
rotation of the axis of the Lucite part and thus of the head of the animal
with the center of the detector FOV. To avoid unwanted x-ray attenuation
and strong x-ray scattering all the part exposed to x-rays (also the screws)
are manufactured in plastics (No. 1-4). Figures 8.2 show a photo of two mice
and a photo of a mouse mounted on the holder realized for the experiment.
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Figure 8.1: Scheme of the animal holder realized for the in vivo experiment for tumor
brain studies. The upper parts of the holder are manufactured in plastic to assure a
minimum x-ray attenuation (1-4). Other parts are fabricated in aluminum to achieve high
mechanical stability (5-10). The parts 4 and 7 are adjustable to the height of individual
animals.
(a) (b)
Figure 8.2: Photos of two nu/nu mice (a) and a mouse fixed for the CT scan on the
holder (b).
8.1.2 Animal description and preparation
Following the successful ex vivo experiments using the F98 cell line (pre-
sented in Section 6.2), which mimics the human GBM in a mouse models,
it has been decided to continue the in vivo trials with this model. More-
over, the size of the animals fits better to the FOV provided by the detectors
available at the SYRMEP beamline.
For the experiment three groups of nu/nu mice have been prepared. Two
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groups consisting of 6 and 7 mice have been injected with 100 000 and 200 000
gold loaded F98 cells respectively. A third group of 3 mice was injected with
200 000 F98 cells without marker (naïve control group). The injections have
been performed on the same day, but depending on the actual date of the
data acquisition the incubation varied from 6.5 to 8.5 days (as summarized
in Table 8.1).
Special attention was drawn on a proper anesthesia of the animals. Dur-
ing data acquisition the animal should be fixed motionless or at least with a
precision better than about half of the detector PSF. The chosen anesthesia
consisted in a cocktail of zoletil 20 mg/kg and xilazine 20 mg/kg that pro-
vide an unconsciousness state of about 1 hour. The injection was carried out
subcutaneously using a syringe. The anesthesia takes effect approximately 5
minutes after the injection. Once anesthetized the animal was fixed on the
holder and data acquisition has started.
Table 8.1: Mice description with the days after the cells injection and the weights.
Sample name No. cells Gold Injection days Weight [g]
FB10-100k-1 100 000 Yes 7.0 26
FB10-100k-2 100 000 Yes 8.0 24
FB10-100k-3 100 000 Yes 8.0 27
FB10-100k-4 100 000 Yes 8.5 22
FB10-100k-5 100 000 Yes 8.5 22
FB10-100k-6 100 000 Yes 8.5 19.7
FB10-200k-1 200 000 Yes 6.5 33
FB10-200k-2 200 000 Yes 7.5 24.7
FB10-200k-3 200 000 Yes 7.5 30.1
FB10-200k-4 200 000 Yes 7.5 24
FB10-200k-5 200 000 Yes 7.5 26.2
FB10-200k-6 200 000 Yes 7.5 22.8
FB10-200k-7 200 000 Yes 8.0 25
FB10-200k-Naïve-1 200 000 No 7.0 32
FB10-200k-Naïve-2 200 000 No 8.0 26.6
FB10-200k-Naïve-3 200 000 No 8.5 24
8.2 Imaging parameters
8.2.1 Low resolution in vivo measurement
The experiment parameters are summarized in Table 8.2. All samples
have been scanned twice collecting vertically two successive virtual stacks of
3.8 mm thickness featuring a small overlap. The total acquisition time for
one entire scan is in the order of 20 min and is determined by the readout
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time of the detector. For the model used the minimum exposure time per
projection is 0.8 seconds. To match this requirement a 4 mm aluminum filter
was used to adjust the incident photon flux within the dynamic range of the
detector. Another bottleneck is represented by the limited rotator speed and
the angular momentum on the mouse during the acquisition. Therefore it
is stated explicitly that the exposure times quoted here are limited by the
available instrumentation. Using faster detectors and more rapid rotation
stages the acquisition times can be substantially reduced and are limited by
the biocompatible dose rate only. The effective scan time is 4.8 min that
can be reduced to ∼ 30 s removing the 4 mm of aluminum used. Figure 8.3
shown the experimental hutch during the experiment where the instruments
used are indicated in its position.
Table 8.2: Experiment parameters of the in vivo experiment.
Parameter Value
No. projections 360
Pixel size 56 µm
Scan angle 180◦
Energy 24 keV
Filters 4 mm Al
Exposure 0.8 s
Read out 2.9 s
Effective scan ∼ 5 min
Total scan ∼ 22 min
IC current 52 ÷ 65 pA
Total entrance dose 86 ÷ 95 mGy
Source-Sample distance ∼ 24 m
Sample-CCD distance 40 cm
Beam on CCD 3.8 × 28.2 mm2
Hutch temperature 25.5◦C
Hutch humidity 40 %
8.2.2 High resolution ex vivo measurement
As stated in the beginning of the Chapter the protocol the animals had to
be sacrificed post in vivo measurements. The heads of the animals have been
sectioned and have been preserved in 10% PFA inside a sealed syringe. In
order to compare the detail visibility of low dose CT with high dose CT the
heads of some animals used in the in vivo experiments have been scanned
again post mortem using the typical ex vivo parameters (as described in
Chapter ??). The detector was the same but the 40 µm thick fluorescent
screen has been replaced with the 20 µm one that provide a higher resolution
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Figure 8.3: Photo of the experimental hutch during the in vivo experiment with the
collocation of the tools used.
but a lower efficiency. The CCD was operated in binning 1 mode (14 µm
pixel size) resulting in a PSF of ∼ 34 µm. The number of projections has
been 900 over 180◦.
8.2.3 Dose measurement
During all CT acquisitions the photon flux was measured in situ by a
full field longitudinal ionization chamber (IC). The photon flux φ on the IC
measured in [ph/mm2/s] has been calculated using the formula:
φ =
I
s(1− e−µgasxgas)
Wgas
ecE
[8.1]
where I is the chamber current [A], Wgas is the energy necessary to produce
a ion pair (that is 33.85 [eV] using air), s is the beam cross-section on the
IC, ec the electron charge magnitude [C], E the photon energy [eV], µgas the
gas attenuation coefficient [cm−1] and xgas is the gas thickness into the IC
[cm]. Then the flux on the sample has been obtained taking in account the
beam source-IC, the source-object distances, the pressure, the temperature
and the air attenuation. The sample entrance dose is:
dose = φ
(
µ
ρ
)
E¯abtexp [8.2]
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where µ/ρ is the mass attenuation coefficient for the medium where the dose
is calculated, E¯ab is the part of the kinetic energy transferred to electrons
that contributes to ionization [45] and texp the exposure time. The total
entrance dose has been obtained multiplying the single projection entrance
dose in air times the number of projections. The in vivo total entrance doses
has been ranging from from 86 ÷ 95 mGy whereas the ex vivo has been 4.6
÷ 5.2 Gy.
8.3 Results
The analysis of the imaged 16 mice shows the normal biological variety
of animals that respond in different ways to the tumor, which in fact is not
surprising for a GBM. In general the experiments have demonstrated the
technical feasibility to locate and subsequently to track gold loaded tumors
in vivo in mice at an x-ray entrance dose of about 100 mGy. Both groups
injected with 100 000 and 200 000 gold loaded F98 cells present small details
(ranging around 100 ÷ 150 µm). This is in line with the experience gained
in the ex vivo experiments, which revealed that in most of the samples these
higher attenuation coefficient details have not a well-grown tumor structure.
In three samples, also larger and spherical details (∼ 500 µm) with a tumor
like shape are visible (FB10-100k-3, FB10-100k-6, FB10-200k-4). This means
that the CT images imply a growth of tumors only in 3 animals out of 13. As
in post mortem experiments the three naïve samples do not show any details.
In the following the three mice showing a tumor-like detail are analyzed and
presented combining in some cases the information retrieved on the in vivo,
ex vivo and MRI measurements.
FB10-200k-Naïve-3
Sample FB10-200k-Naïve-3 has been injected with 100 000 naïve F98
cells and it has been scanned in vivo after an incubation time of ∼ 8.5 days
(208 hours). Subsequent to the in vivo experiments it has been sacrificed
and prepared for the high resolution CT scan as mentioned before. The air
entrance dose applied to the head has been 94.1 ± 1.9 mGy for the in vivo
scan and 4.6 ± 0.10 Gy for the ex vivo scan. This port mortem sample has
been also examined using a Bruker 9.4 T MRI scanner. The sequence used
was a 3D Flash (gradient echo). The acquisition parameter was TE = 10 ms,
TR = 34 ms, flip angle α = 30◦, pixel size 60 µm and FOV 256 × 198 × 256
corresponding to 15.3 × 11.9 × 15.3 mm3. The acquisition took ∼ 9 h.
Figure 8.4 shows the comparison of two virtual slices at the axial height
of the injection hole obtained in both modalities, with in vivo x-ray CT
and ex vivo MRI, respectively. The x-ray CT in Figure 8.4(a) confirms that
the injected tumor is not visible because of the very similar attenuation of
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tumor and brain tissue. Close to the injection hole a region of lower x-
ray attenuation is pronounced that could be interpreted as an edema which
developed subsequent the injection procedure. In the MRI in Figure 8.4(b)
a similar region can be identified and can be interpreted in the same way.
Moreover, in MRI a tumor featuring a diameter of ∼ 3.4 mm is well visible
also because of a surrounding interface (black boundary) that engulfs it.
5 mm
(a)
5 mm
(b)
Figure 8.4: X-ray CT slice acquired in vivo of the mouse FB10-200k-Naïve-3 injected
with naïve F98 cells (a) and its analog in post mortem MRI (b).
The surrounding interface is visible in MRI only and not in the x-ray CT.
It indicates that the missing signal can not be an edema (visible with x-ray)
but could be an accumulation of blood. To shed light on the origin of this
signal and to proof this hypothesis it would require another complementary
method such as histology. Summarizing, the complementary imaging tech-
niques indicate an edema near the injection hole and most probable a blood
accumulation around the tumor which enhances the tumor visible indirectly
in MRI.
FB10-200k-4
Sample FB10-200k-2 has been injected with 200 000 gold loaded F98 cells
and it has been scanned in vivo ∼ 7.5 days after the injection (181 hours). As
in the previous case subsequent to the in vivo scan it has been sacrificed and
prepared for the high-resolution ex vivo CT. The air entrance dose applied
to the head has been 86.7 ± 1.7 mGy for the in vivo and 5.20 ± 0.10 Gy for
the ex vivo scan. The post mortem sample has been scanned also in MRI
using the same parameters as in case of the FB10-200k-Naïve-3 sample.
Depicted in the panels of Figures 8.5 is a comparison between the 3D
x-ray renderings of the low dose in vivo scan in Figure 8.5(a), the high dose
ex vivo scan in Figure 8.5(b) and two zooms of the tumor in full image reso-
lution for the two modalities, respectively in Figures 8.5(c) and 8.5(d). The
total air entrance doses have been 86.7 ± 1.7 mGy and 4.6 ± 0.5 Gy. Using
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the IDL procedure described before image segmentation and subsequent de-
termination of tumor volume and of the attenuation coefficient µ has been
applied on both, the in vivo and ex vivo data (results reported in Table 8.3).
Figures 8.6 shows reconstructed image slices in axial and sagittal plane of
5 mm
(a)
5 mm
(b)
500 μm
(c)
500 μm
(d)
Figure 8.5: Comparison of the sample FB10-200k-4 head (a-b) and detail (c-d). 3D
renderings have been obtained with low dose in vivo scan (a-c) and with high dose ex vivo
scan (b-d). These images and the following ones are obtained using the software OsiriX.
about the same area in x-ray CT (Figures 8.6(a)-8.6(c)) and MRI (Figures
8.6(b)-8.6(d)). The x-ray CT shows the tumor signal in brighter shading. It
is well visible in both the views. The analog in MRI presents the same detail
at the same position. As already seen in naïve MRI image in Figure 8.4(b),
also here the tumor is embedded in a region that features a dark shaded sig-
nal (probably due to blood) and enhances the tumor presence. The tumor
diameter of the gold loaded tumor is much smaller (∼ 0.5 mm) than in case
of the naïve cells (∼ 3.4 mm), which indicates a slower growth of the marked
tumor.
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Table 8.3: F10-200k-4 detail measurement results.
Volume [µm3] µ [cm−1]
in vivo (4.3 ± 1.0) × 107 0.87 ± 0.03
ex vivo (4.4 ± 1.1) × 107 0.95 ± 0.06
5 mm
(a)
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(b)
5 mm
(c)
5 mm
(d)
Figure 8.6: Comparison of the sample FB10-200k-4 head scan acquired with in vivo
x-ray CT in axial (a) and sagittal (c) views and its analog in ex vivo MRI (c-d).
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FB10-100k-3
Sample FB10-100k-3 has been injected with 100 000 gold loaded F98 cells
and it has been scanned in vivo ∼ 8 days after the injection (191 hours). As
in the previous examples it has been sacrificed after in vivo scan and has
been prepared for the high resolution CT scan. The entrance dose in air
applied to the head was 86.7 ± 1.7 mGy for the in vivo and 5.14 ± 0.10 Gy
for the ex vivo scan. The Figure 8.7 show the comparison between the in vivo
and ex vivo scans. A large spherical detail (with a diameter of ∼ 0.5 mm) is
visible in both modalities. It is surrounded by smaller details characterized
by less intense signal. Obviously the sensitivity of the ex vivo result permits
to visualize more details with respect to the in vivo measurement where it
is not possible to appreciate all the smaller details. Despite that the volume
and attenuation measurements on the main tumor gives compatible results
(shown in Table 8.4). With respect to the FB10-200k-4 mouse, within the
error bars the mean attenuation of the segmented tumor is slightly smaller.
5 mm
(a)
5 mm
(b)
1 mm
(c)
1 mm
(d)
Figure 8.7: Comparison of the 3D renderings obtained with low dose in vivo scan (a-c)
and with high dose ex vivo scan (b-d) of sample FB10-100k-3.
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Table 8.4: F10-100k-3 detail measurement results.
Volume [µm3] µ [cm−1]
in vivo (6 ± 2) × 107 0.89 ± 0.05
ex vivo (4.7 ± 1.4) × 107 0.96 ± 0.06
FB10-100k-6
Sample FB10-100k-6 has been injected with 100 000 gold loaded F98 cells
and it has been measured in vivo ∼ 8.5 days after the injection (207 hours).
This sample has been scanned only in the in vivo modality. The in vivo
entrance dose in air applied to the head was 94.1 ± 1.9 mGy. Depicted in
Figure 8.8 are the 3D rendering of the x-ray CT data and a zoom of the tumor
in full frame resolution. Image segmentation and subsequent determination
of tumor volume and of the attenuation coefficient µ has been applied on the
data set and are summarized in Table 8.5.
5 mm
(a)
500 μm
(b)
Figure 8.8: 3D rendering of the head of the sample FB10-100k-6 (a) and a zoom of the
detail (b) obtained with low dose in vivo scan.
Table 8.5: F10-100k-6 measured volume and attenuation coefficient of the detail.
Volume [µm3] µ [cm−1]
in vivo (3.4 ± 0.8) × 107 0.86 ± 0.04
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8.4 Tumor attenuation estimation
Since the incubation time for the tumors in the samples FB10-200k-4,
FB10-100k-3 and FB10-100k-6 are different it is possible to a certain extend
to estimate the tumor growth. For this the measured values of the linear
attenuation coefficient derived from the image segmentation of the three
samples are shown as function of the incubation time (Figure 8.9). Within
the error bars the progress of the tumors in time follows an exponential
decay. The solid line, which guides the eye is therefore an exponential fit on
the linear attenuation coefficient (µ) versus time using the following function:
µtumor(t) = c0 + c12−t/c2 [8.3]
where t indicates the incubation time and c0, c1 and c2 are fit parameters.
This formula takes into consideration that in every mitosis the gold concen-
tration decays as a factor of two. Having only three points (and a three
parameters function) the freedom degrees have been reduce fixing c0 and c1
using two boundary conditions, that are: 1- on the long term (or for multi-
ple mitosis) the attenuation coefficient of the tumor µ will approximate that
of the brain value (0.57 cm−1); 2- at the moment of implantation at t = 0
the gold loaded cells have the attenuation measured on the basis of mass
spectroscopy as presented in Section 4.1 of 2.37 cm−1). In that way the fit
function becomes:
µtumor(t) = 0.57 + 1.8 · 2−t/c2 [8.4]
with one free parameter. The result gives c2=82 ± 3 hours (χ2/ν = 0.194)
that represents a measure of the tumor doubling time.
This doubling time should be interpreted prudently as a coarse estimation
since it has been calculated using different beings, which obviously feature
biological differences that certainly influence the result. Nevertheless it shows
that the method provides the possibility to study qualitatively tumor growth
and enables to measure for example cell-doubling times. Applied longitudinal
to an individual animal in vivo such a method can yield valuable information
on tumor growth or the effects of tumor therapies.
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Figure 8.9: Graph of the linear attenuation coefficient of the details measured on the
samples in function of the scanning time after the injection procedure.
8.5 Estimate of photons attenuated into the brain
Up to now only the entrance x-ray dose in air has been quoted, which
is a common measure to evaluate the radiation dose applied to the sample.
However, it is often necessary to know the effective dose to specific organs
because of their different responses or sensitivity to radiation. The CT model
obtained from the experiment together with the measurements provide a
perfect starting point for a simulation that keep trace of the pixel positions
of the attenuated photons.
A single one pixel thick mouse slice has been used for a dose-tracing
simulation. The simulation is based on the IDL code described in Chapter
7. A segmentation of the different components such as air, tissue, brain,
skull and plexiglass holder within the aforementioned reconstructed slice has
been performed and the theoretical attenuation value at 24 keV has been
assigned to each of those components as depicted in Figure 8.10(a). Here
black color represents air (5.56 × 10−4 cm−1), light blue the plexiglass holder
(0.40 cm−1), orange is used for tissue (0.57 cm−1), light brown is the brain
(0.57 cm−1) and white is used for the skull (3.15 cm−1).
A certain number of photons impinge in randomly fashion to the model
slice with the “good geometry” approximation used also in Chapter 7. The
photons are tagged as absorbed if a probability test on a pixel by pixel
is successfully passed. In Figure 8.11 the procedure is clarified by means
of an example. Six photons are sent over a three voxel model made by
tissue, skull and brain in sequence. For each photons and voxel a random
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(a) (b)
Figure 8.10: (Left) The mouse slice used as model. The black color represents air, the
light blue the plexiglass holder, orange the tissue, the light brown the brain and white
the skull. The geometry has been retrieved from a real CT of the in vivo experiments.
(Right) A representative result of the simulation, a lighter gray represents a higher number
of photons absorbed and subsequently a higher dose in the voxel.
number is generated. Depending on the attenuation property of the voxel
the photon can pass onto the subsequent voxel or be counted as absorbed.
This probability test based on the attenuation coefficient of the model is
repeated for each voxel in the linear path until the photon is absorbed or it
exits the sample.
photons
IN
photons
OUT
e ee-μ       Δx -μ      Δx -μ       Δxbrainbonetissue
n     = 1 n    = 2 n    = 1tissue bone brain
Figure 8.11: Example of the procedure used to estimate the delivered x-ray dose to the
brain. Each of the six photons sent onto the three pixel sample (impinging on the left
hand side) has to pass a probability test depending on the “pixel material” to reach the
next pixel. A map of the absorbed photons is kept to visualize the model.
In the example shown in Figure 8.11, one photon is absorbed by the tissue
voxel, two by in the skull voxel, one in the brain voxel and two pass through
the model without interaction. The same principle is applied on the mouse
slice model for each projection angle. The number of projections is the same
as used in the CT scans of the in vivo experiments. It is worth mentioning
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that this is a coarse and overestimated approximation of the photon energy
distribution within the model because scattering processes are counted as
absorbing processes. Nevertheless it provides a semi quantitative approxi-
mation of the effective absorbed dose at different anatomical locations. De-
picted in Figure 8.10(b) it a representative result of the simulation. In this
representation lighter shading represents more absorbed photons thus dose
in the voxel.
Obviously the higher attenuation coefficient in a voxel the more photons
are absorbed therein. Now it is possible to calculate the ratio between the
absorbed photons of each component and the total number of photons sent
onto the sample as summarized in Table 8.6. About 45 % of the impinging
photons are transmitted and are available for the images formation. The
skull absorbs ∼ 15 %, the tissue ∼ 25 %, the holder ∼ 4 % and the air ∼
0 %. The interesting result is the brain attenuation of only ∼ 11 % that
means that only ∼ 11 % of the total photon energy is deposited into the
brain, which is the most sensible mouse organ irradiated in our experiment.
Component Absorbed fraction
Skull ∼ 15%
Tissue ∼ 25%
Brain ∼ 11%
Lucite ∼ 4%
Air ∼ 0%
Non absorbed ∼ 45%
Table 8.6: Table of the absorbed fraction of photons over the impinging photons for each
component.
8.6 Discussion
The experiments discussed here served to demonstrated the feasibility
of tumor tracking in vivo using low dose x-ray CT combined with gold
nanoparticles used as cellular contrast agent. Due to constrains of the legal
authorization longitudinal experiments on an individual animal could not
be preformed. According to the protocol the animals were sacrificed post
imaging. A specific holder for the experiment has been developed and it
worked according to its specifications regarding stability, transparency for
x-rays, adaptability for mice of different sizes etc. A total of 16 mice has
been divided into 3 groups and injected with 100 000 or 200 000 gold loaded
F98 cells or with 200 000 naïve cells. The CT scans have been performed
using the SR at the SYRMEP beamline with a detector pixel size of 56 µm
and 360 projections. The entrance dose in air applied to the animals was
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between 86 ÷ 95 mGy. All the mice containing marked cells show some high
attenuation details in the brain that are stemming from the label. In most
of the cases unorganized cluster of cells (∼ 100 ÷ 150 µm) could be revealed
that might be tumors in early stages. In three samples, larger and spherical
details have been visible (∼ 500 µm). Two MRI scans have been performed
on one of three mentioned samples and in a naïve mouse ex vivo yield ad-
ditional information. This complementary imaging modality confirmed the
correspondence of the tumor with the gold signal measured using x-ray CT.
The ability to measure qualitatively the x-ray attenuation (thus the attenu-
ation coefficient) allows determining the gold concentration versus time. It
could be shown that the method provides the possibility to study qualita-
tively tumor growth and enables to measure for example cell-doubling times
which was estimated to 82 ± 3 hours for the gold loaded F98 tumor cells in
mice.
The experiment confirms the feasibility of in vivo cell tracking in small
mammals at radiation dose compatible with longitudinal studies on the same
animal and the possibility to study in detail for example the dynamic of tu-
mor growth by measuring its volume and shape. Moreover it allows to mon-
itor cell mitosis and the fate of injected cells. As summarized in the review
[96] the delivered radiation dose has been kept very low compared to total
body scans in other applications. Our intention here was to demonstrate
that also with a drastic cut of the dose cell tracking is feasible with SR. For
further widespread of this method a next step would be a translation of the
technique in combination with an x-ray tube. As it was shown in Chapter
?? this should be feasible although slightly higher radiation doses would be
required to obtain a comparable result. The in vivo experiments discussed
in this Chapter are also the first in vivo SR studies of tumors in mice us-
ing non directed contrast agent that open the way for a conventional x-ray
source study of intracranial tumors in mice using µCT. To understand the
state of the art on intracranial tumor, the review [97] published in 2010 in
Methods journal states “To our knowledge, to date there are no publications
exploring intracranial tumors in mice using µCT in an in vivo setting” ex-
cept for Ref [98] that used an injected iodine contrast agent and synchrotron
radiation. Of course, being a proof-of-principle experiment, the same kind of
experiment could be translated to other organs and other cell types. Using
appropriate triggers to avoid motion artifacts due to breathing and/or the
heard beat [96, 97] the method could be applied to cell tracking in lung, kid-
ney and heart in combination with malignant and non-malignant cell lines.
The new contribution of this method is not only the in vivo measurement
in a specific tumor study but is in general the combination of a cell loading
protocol based on gold NPs in combination with in vivo x-ray imaging.
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Conclusions
Cell tracking has potential impact in several sectors of medicine and bi-
ology. As it has been shown in Chapter 1, the combination of classical imag-
ing techniques with cellular marker based on nanotechnologies successfully
demonstrated the feasibility of cell tracking under certain conditions. Several
examples arising from the combination of optical imaging and quantum dots
as contrast agent or of magnetic resonance imaging with superparamagnetic
iron oxide nanoparticles as cellular marker. Nevertheless, such techniques
feature specific drawbacks and at the moment there is not a single technique
that can be considered the perfect investigation tool for cell tracking. Up to
the presented thesis work x-ray CT has never been considered as an appro-
priate cell tracking technique for in vivo studies mainly because of radiation
dose issues. The main goal of the presented work was to demonstrate the
feasibility of x-ray in vivo cell tracking in animal models at low radiation
dose.
In Chapters 2 and 3 the properties of the x-ray CT and the instrumen-
tation available at the laboratories in Trieste have been investigated with
the aim of identifying a specific cellular contrast agent able to exploit the
inherent properties of x-ray CT. Gold nanoparticles turned out to be the
most promising solution because of its high x-ray attenuation coefficient and
its biocompatibility.
In Chapter 4 the chosen cell loading protocol based on phagocytosis has
been described. This loading protocol on malignant and non-malignant cells
has been tested. The average gold uptake amongst the different cell lines
was not statistically significantly different. Using complementary methods
such as mass spectroscopy, transmission electron and scanning microscopy it
could be verified that the mass and, hence, number of nanoparticles taken up
by the different cell types were, thus, very similar. With the results yielded
it has been possible to theoretically evaluate the visibility of such marked
cells in an x-ray CT modality. It turned out that the gold based contrast
agent, indeed, is a suitable marker in combination with x-rays to render cells
in a living being.
In Chapters 5 and 6 the theoretical prediction has been experimental
tested in in vitro and ex vivo. In particular the in vitro experiments revealed
that the x-ray CT method allows to render a single gold loaded cell in its
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natural environment in great detail at a reasonable radiation dose. Thus
the spatial resolution provided by this method outperforms what is really
required for in vivo cell tracking. Even with a system based on a conventional
µ-focus x-ray tube the sensitivity has been very close to single cell resolution.
The ex vivo experiments on rodents confirmed these findings. Using different
cell lines and animals gold loaded cells could be rendered with a sensitivity
close to ten cells in different anatomical locations.
To path the way towards x-ray based in vivo cell tracking in animal
models of human diseases Chapters 7 and 8 answered the remaining ques-
tion regarding radiation dose issues. Utilizing Monte Carlo simulations and
specific ex vivo experiments, the effects of low dose x-ray exposure has been
explored in terms of image quality and cells visibility, taking into account
the dilution of the marker due to cell mitosis and the spatial resolution of
the imaging system. It turned out that even for a very low dose (∼ 100
mGy) the resulting lower resolution of ∼ 100 µm does not compromise the
capacity to disclose small clusters of marked cell in living beings. Finally, the
first successful in vivo x-ray cell tracking experiments have been carried out
at SYRMEP beamline on a mouse model of the human glioblastoma brain
tumor using gold loaded glial cells (F98). The implanted gold labeled cells
have been correctly detected in the brain of mice with a spatial resolution of
∼ 117 µm at a dose of ∼ 90 mGy. It was possible to determine the tumor
volume and subsequently cell numbers. The delivered radiation dose has
been kept at very low level to demonstrate that cell tracking using x-rays is
feasible over a long period in an individual animal.
Similar to already established cell tracking techniques the investigations
carried out in the frame of this thesis work also revealed few inherent techni-
cal limitation in x-ray CT cell tracking. Nevetheless, the presented work has
demonstrated the effectiveness of the combination of x-ray CT and a cellular
marker based on gold nanoparticles in cell tracking in vivo. Eventually the
method can be considered an attractive alternative for cell tracking.
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